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INTRODUCTION 
Infectious bovine keratoconjunctivitis (IBK) Is a contagious, costly 
eye disease In cattle. Moraxella bovls Is the cause of this disease. 
The M. bovls bacteria are short, gram-negative, non-motile and rod 
shaped. Cattle with this disease exhibit heavy tearing, swollen eyelids 
and eyes that are very sensitive to sunlight In the Initial stage. Then, 
conjunctivitis, keratitis, corneal ulceration and scarring appear in the 
late stage. Ultraviolet radiation, face flies and mechanical irritants 
can enhance the progress of this disease. If possible, the treatment 
with antibiotics should be done in the early stage. Present treatment 
methods Include the topical application of eye drops, sprays, and 
powders, subconjunctival and Intramuscular Injections. However, single 
treatments do not maintain therapeutic levels of drug for the 5 to 7 days 
necessary for disease control. Repeated medications are necessary to 
suppress the disease. 
To solve this problem, a controlled release system of tylosin 
tartrate in hydrogel ocular Inserts has been studied in a series of in 
vitro experiments (Ryoo, 1986). In in vitro experiments, a drug release 
rate above the therapeutic level necessary for suppressing the bacteria 
for 9 days has been maintained. This time duration of release is more 
than sufficient for the treatment. 
In"order to evaluate the effectiveness of ocular Inserts, in the 
current work two major experiments were performed in vivo: (1) infection 
tests in which the bacterial growth was monitored for 14 days, and (2) 
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retention tests in which the ocular insert was tested for retention 
effectiveness in healthy and in infected bovine eyes. 
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LITERATURE REVIEW 
Nature of Infectious Bovine Keratoconjunctivitis (IBK) 
General 
Infectious bovine keratoconjunctivitis (IBK) is an ocular disease 
characterized by epiphora (excessive lacrimlnal discharge), photophobia, 
blepharospasm, conjunctivitis, keratitis (corneal opacity), corneal 
ulceration and corneal scarring. It is commonly called "pinkeye" of 
cattle. Other names for this disease are New Forest disease, infectious 
ophthalmia, and Infectious keratitis (Gelatt, 1981; Hughes, 1981). In 
1889, Billings first reported pinkeye to be caused by short, thin bacilli 
with rounded ends. Bamer (1952) concluded that keratitis was caused by 
Moraxella bovls, and Moraxella bovis is today considered to be the cause 
of IBK. IBK is a disease occurring perennially wherever cattle are 
raised. However, pinkeye is highly prevalent, particularly in summer 
months and has a high incidence in beef cows and calves, stock cattle, 
and replacement females. The infection is extremely contagious, and once 
pinkeye has entered the herd, all animals should be treated. 
Transmission of the infection can occur by direct contact with ocular 
secretions, nasal secretions, or by face flies. 
Economic importance 
Pinkeye is a costly disease. The disease is rarely fatal, but it 
may result in a major economic loss. Losses result from decreased weight 
gain, drop In milk production, delays in breeding, the cost of treatment 
and a reduced sale price for cattle with ocular scars. The U.S. 
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Department of Agriculture (1976) estimated that 20% (about 10 million) of 
beef calves and 10% (3 million head) of feedlot cattle develop pinkeye. 
It is estimated that the U.S. beef industry loses more than 150 million 
dollars each year. This value did not Include an estimate for the loss 
of production of milk in dairy cattle. In Australia, Frlsch (1975) 
reported that calves with pinkeye at 15 months of age weighed an average 
of 50 lbs lighter than those of the same age that were not Infected. 
Killlnger et al. (1977) have reported that calves with both eyes Infected 
lost considerably more weight than calves with only one Infected eye. 
Etiology 
Many organisms have been associated with IBK, but only the 
bacterium, Moraxella bovis, has been shown to cause the disease by 
itself. M. bovls is a short plump, gram-negative, non-motile rod with 
rounded ends in pairs or in short chains. The cells are from 0.5 to 1.0 
um in width and from 1.0 to 2.0 um in length (Hughes, 1981). 
Characteristics of bovis colonies on blood agar Include the 
following: (1) gram-negative, (2) beta-hemolytlc, (3) oxidase-positive, 
(4) nitrate-negative, and (5) no growth on MacConkey's culture medium 
(Fraser and Gilmour, 1979; Veterinary Learning Systems Co., 1987). 
Colonies are 1.0 to 3.0 mm in diameter with a zone of beta hemolysis 
about 0.5 to 1.0 mm in width after incubation for 24 hr at 37°C (Hughes, 
1981). TWO colony types can be distinguished: (1) large, flat, rough 
and non-corroding, and (2) most often smaller, convex, smooth, and 
corroding forms (Rosenbusch, 1983; Federsen et al., 1972). Pugh and 
Hughes (1970) reported that the use of 10% magnesium chloride in liquid 
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medium prevented virulent strains (smooth colonies) of M. bovis from 
autoagglutlnating. This permitted the counting of bacteria in a sample 
using plate counting or microscope counting techniques. After further 
incubation at 25°C, the size of colonies was seen to increase to 3.0 to 
4,0 mm diameter and the zone of hemolysis became 1.0 to 1.5 mm in width. 
Important virulence factors of ^  bovis are pill and hemolysin. 
Pill, as attachment factors, assist in the adherence of the bacterium to 
the cornea and conjunctiva to allow colonization by the microorganism 
(Pedersen et al., 1972). Once attached, the cells are exposed to certain 
toxins produced by M. bovis (e.g., hemolysin) that enable the bacteria to 
penetrate the eye. The cornea-damaging substances (e.g., hemolysin) 
cause degeneration of the epithelium, ulceration, and deep invasion by 
the organism (Veterinary Learning Systems Co., 1987). 
Predisposing factors 
Although IBK occurs throughout the year, it is more prevalent during 
the warm and humid months of summer. This tendency has been attributed 
to a number of factors (Punch and Slatter, 1984). These predisposing 
factors include exposure to ultraviolet light, the degree of pigmentation 
around the eye (a major factor for variation in breed susceptibility), 
the presence of face flies as carriers of the organism, nutritional 
deficiencies (vitamin A), possible presence of infectious bovine 
rhlnotracheitls (IBR) virus infection and use of modified live IBR virus 
vaccines during pinkeye season, mechanical irritants such as dust, tall 
grass seed, and wind (Hughes et al., 1965; Veterinary Learning Systems 
Co., 1987; Punch and Slatter, 1984). Predisposing factors may allow 
M. bovis to invade the eye more easily than without these factors and to 
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disrupt host cells accentuating the damage (Veterinary Learning Systems 
Co., 1987). 
Ultraviolet (UV) radiation plays a role as a major predisposing 
factor in increasing corneal susceptibility to bovis. The annual peak 
of ultraviolet radiation is positively correlated with the peak of 
incidence of IBK in the field (Hughes and Fugh, 1970). A heavy dose of 
ultraviolet radiation is thought to alter the ocular cell surface so that 
intercellular spaces are widened and less completely sealed (Veterinary 
Learning Systems Co., 1987). This permits the microorganism to invade 
more easily. Recognizing this, Hughes et al. (1965) used ultraviolet 
radiation produced by sunlamps (wavelength: 2880 - 3100 1) to produce IBK 
in calves confined Indoors. 
Cattle that lack pigment around their eyes also have a higher 
incidence of IBK (Ward and Nlelson, 1979; Caspari et al., 1980). The 
presence of carrier insects such as face flies is also an important 
factor. The Increase in population of the face fly is associated with 
the an increase in the incidence of IBK. Mechanical irritation to the 
conjunctival sac and transportion of the organism might be done by the 
flies (Brown and Adklns, 1972; Steve and Lilly, 1965). Gerhardt et 
al. (1982) reported that the incidence of IBK was decreased due to fly 
control. 
Pugh and Hughes (1971) reported that Infectious bovine 
rhinotracheitis (IBR) virus infection is an enhancing factor, aiding to 
the pathogenicity of IBK, since the virus is associated with a 
conjunctivitis form of disease. Mycoplasma also exhibited similar 
results (Langford and Dorward, 1969; Rosenbusch and Knudtson, 1980). 
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The age of the animal seems to play a role in enhancing the disease. 
Young animals tend to be more susceptible to pinkeye infection as 
immunity develops in cattle which have been previously exposed to 
M. bovis (Hughes and Pugh, 1970). 
Wind, dust, tall grass and seed pods from tall grass also have been 
suggested as factors responsible for corneal irritation, and thus 
contribute to Increasing the incidence of pinkeye (Hughes, 1981; 
Veterinary Learning Systems Co., 1987). 
Clinical signs 
The earliest clinical signs of IBK are photophobia (sensitivity to 
light), blepharospasm (blinking or closing the eye) and epiphora 
(excessive tearing) followed by conjunctivitis (hyperemia and edema of 
conjunctiva). If an eye infection becomes severe after two days, a white 
spot (keratitis) will appear near the center of the cornea. The opacity 
of cornea results from the loss of its transparency due to fluid 
retention. Then, this area rapidly enlarges and the overlaying 
epithelium may slough, forming a corneal ulcer. This ulcer usually 
Involves the epithelium and adjacent anterior stroma only (Gelatt, 1981). 
As the disease progresses in the eye without any treatment, a 
corneal ulcer may penetrate the cornea. Then, this ulceration can result 
in a corneal scar and the ulcer perforates the cornea. With penetration, 
the Interior ocular structures are Infected, and loss of the eye results. 
The cornea changes in color from a pale yellow to white. Throughout this 
time. Infected animals may exhibit a weight loss or reduction of milk 
production due to Inflammation and pain, and the inability of the animal 
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to compete for food with other cattle. The cornea will vascularize 
eventually. In less severe cases, an infected eye will heal within 3 to 
6 weeks. Vascularization of the cornea proceeds rapidly toward the 
primary lesion. As the vascularization (repair) process continues, acute 
signs subside. As neovascularization reaches the center of cornea, the 
transparency of the cornea is restored as part of the repair process. 
In young animals, the disease process is usually more severe than in 
old animals. Also, a long repair period (Gelatt, 1981) is needed. 
Clinical signs and healing processes may be different depending on the 
breed of animal, husbandry, and management (Hughes, 1981). 
A tabulation of the clinical signs of the disease is shown in Table 
1 as described by various Investigators. Jackson (1953) described five 
types of IBK based on the severity of clinical signs. However, Pugh et 
al. (1982) divided the signs into four stages based on the severity of 
lesions. Also, Killinger et al. (1976) described a method of scoring 
lesions. In their eye-scoring system, they assigned scores in three 
major parts: a 10 to normal eyes, 11 through 14 to eyes with active 
corneal lesions, and 21 through 24 to eyes with healing or healed lesions 
(corneal scars). 
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TABLE 1. Various clinical signs of IBK based on the severity of the 
disease 
Author Type Description of clinical signs 







a comparative mild conjunctivitis and 
keratitis 
more severe form with some corneal 
ulceration 
severe keratoconjunctivitis with formation 
of descemetocele and possible loss of the 
eye due to rupture of the anterior chamber 
severe ulceration, panophthalmitis, 
general bilateral, blindness, occasional 
death due to an ascending Infection 
persistent lacrimlnation in some cases but 
the majori^  show no signs of Infection 
Pugh grade 1 - small ulcer (1-2 mm) healed without 
et al, corneal vascularization 
(1982) 2 - ulcer (3-4 mm) healed without corneal 
vascularization 
3 - corneal change from permanent scar; 
healed with corneal vascularization 
4 - more severe than grade 3 
Kllllnger score 10 - normal eye 
et al. 11 - active lesion involving one-third or less 
(1976) of cornea 
12 - active lesion involving one-third to two 
thirds of the cornea 
13 - active lesion involving two-thirds or 
more of the cornea 
14 - active lesion with cornea perforation 
21 - healing or healed lesion on one-third 
or less of the cornea 
22 - healing or healed lesion involving 
one-third to two-thirds of the cornea 
23 - healing or healed lesion involving 
two-thirds or more of the cornea 
24 - healed blind eye including phthisical 







moist eyes or slight tearing 
ulceration stage concomitant with drooping 
of eyelids 
period of vascularization when corneal 
repair process predominates 
the time when scar tissue resolves 
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Prevention and Treatment 
Immunization and vaccination 
The presence of several infecting strains of M. bovis has prevented 
the development of efficacious bacterins (Hughes, 1981). Whether or not 
immunity to IBK infection is due to a local immune response or is due to 
a generalized immune response is still a controversial question (Kopecky 
et al., 1983; Weech and Renshaw, 1983). A good vaccine against M. bovis 
includes pilus antigens which prevent adhesion of the organisms to ocular 
tissues, thereby preventing infection (Veterinary Learning Systems Co., 
1987). This vaccine can reduce both the incidence and severity of 
infection. TWo of the four vaccines developed are now commercially 
available. Conventional bacterins have been shown to be less effective 
than the vaccines that are rich in pilus antigens. 
Hughes et al. (1979) compared the efficacy of vaccination with 
antibiotic treatment. They concluded antibiotic treatment was more 
effective as a prophylaxis against IBK infection than vaccination. Since 
an effective vaccine is difficult to produce, the use of good husbandry 
techniques and treatment with antibiotics may offer a better alternative 
to control IBK than by using vaccinations (Hughes et al., 1979; Fugh et 
al., 1982). 
Local and systemic therapeutic measures (medical treatment) 
If the disease is treated in the early stage of the infection before 
corneal damage occurs, all types of therapeutic measures seem to be 
successful (Veterinary Learning Systems Co., 1987). Before treatment, 
microbiological examinations and antibiotic susceptibility tests must be 
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considered in selecting the right antibiotic. Prior to the use of 
antibiotics and sulfonamides, a varieQr of compounds such as zinc 
sulfate, boric acid, mercury and cyanide salts, silver nitrate and copper 
sulfate were shown to be beneficial in the treatment of IBK (Jones and 
Little, 1924; Mitter, 1915). 
Present IBK treatment methods consist of topical applications of 
antibiotics and sulfonamides as eye drops, powders, sprays, or ointments. 
Ointments are preferred. However, since tears rapidly wash the drug from 
an eye, therapeutic levels of drug can not be maintained during the 
therapy, and drugs must be applied repeatedly. Cattle with a severe 
corneal ulceration may be treated by applying subconjunctival injections 
of antibiotics (plus a corticosteroid to reduce inflammation). However, 
repeated injections may be needed to maintain antibiotic levels of drugs. 
Also, systemic antibiotics have been shown to be effective in reducing 
the severity of clinical diseases as well as eliminating the carrier 
state. Pugh and McDonald (1977) administrated long-acting 
oxytetracycline intramuscularly to calves infected with IBK. At a dosage 
of 7 mg/kg body weight, ten out of fifteen calves remained infected. 
However, a higher dosage (11 mg/kg body weight) left only five calves 
infected. Table 2 shows some commonly used products among the present 
commercially available products for treating pinkeye in cattle (Weber et 
al., 1988; Veterinary Learning Systems Co., 1987). 
Third eyelid flaps and tarsorrhaphy (suturing the upper and lower 
eyelid together) are frequently used for the treatment of severe 
ulcerative keratitis in order to preserve the eye. Prior to closing the 
eye, antibiotics and corticosteroids are administrated by subconjunctival 
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TABLE 2. The present commercially available products for treating IBK 





Major component Cmpany 
furazolidine Norden 
tylosin Elanco Tylarplus powder 
neomycin 









injection oxytetracycline Pfizer 
injection. Third eyelid flaps provide mechanical support to the cornea 
and promote healing of the corneal ulcer by raising temperature and 
increasing metabolism of the tissue (Anderson et al., 1976). In addition 
to medical treatment, good husbandry practices are recommended. These 
include keeping the infected animals in a darkened, dust-free 
environment, supplying good quality food and water, and controlling the 
fly population. Also, it is recommended that eye patches be used which 
shade and protect the affected eye (Veterinary Learning Systems Co., 
1987). 
Since Hawley (1954) used an eye pellet as a drug-contained device to 
apply drugs to the affected eye, controlled drug release systems have 
been used by other researchers as well (Slatter et al., 1982a, b; 
Bloomfield et al., 1978; Theodorakis et al., 1983). 
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Ocular Application of Controlled Drug Release Systems 
When drug delivery to the eye is used, the duration of drug release 
must be long enough to treat the disease, and the drug release levels 
must be constant so that the frequency of drug administration can be 
minimized. Thus, the development of suitable ocular inserts can be more 
valuable than other methods of drug delivery as the development would 
provide drug to the eye at a constant level for a long period of time. 
Although a controlled release system would Ideally show precise, 
reproducible, and predictable release kinetics, the problems of device 
insertion and retention time must be solved. 
The eye has been considered to be a useful site for using controlled 
release systems. Compared to other body sites, it is relatively easy for 
devices to be inserted into the eye and to be removed from the eye. An 
insert is readily prepared by dissolving a drug and a matrix polymer in a 
solvent. The solvent is then evaporated to form a thin film of the 
polymer which can be applied to the various shaped support systems such 
as a cube, solid rectangle, or doughnut, for example. 
Ocular application for the treatment of eye disease for humans 
Before discussing the ocular Inserts for the bovine eye, two ocular 
systems (OcuseriPand Lacriser^ ) for human use, which are already 
commercially available, can be described in order to evaluate aspects of 
efficacy and retention problems. 
(§) 
The Ocusert is a membrane controlled reservoir system to treat 
glaucoma, one of the leading causes of blindness in the world. The 
active drug of this insert is pilocarpine. The polymer for Ocusert is 
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ethylene-vlnyl acetate copolymer. Pilocarpine Is surrounded on both 
sides with two polymer membranes. The major advantages of using Ocusert® 
include: (1) longer duration of drug action (up to 7-8 days) (2) 
convenience of once a week application, and (3) better patient compliance 
with the therapy. However, there are problems of insertion, retention, 
leakage, and discomfort (Conn and Langer, 1984). 
Lacrlsert is valuable for the treatment of patients with dry eyes 
(Keratitis Sicca). This device is a rod-shaped Insert (1.27 mm diameter, 
3.5 mm in length) composed of 5 mg of hydroxypropyl cellulose, a water 
soluble polymer. Lacrlsert is Inserted into the eye by a special 
applicator. If the system is placed In the conjunctival sac, it softens 
within 1 hour and completely dissolves within 14 to 18 hours. This 
device can stabilize and thicken the precorneal tear film and prolong the 
tear film breakup time. The difficulty of using Lacrlsert is insertion 
(Conn and Langer, 1984). 
Ozawa et al. (1983) have prepared hydrogel ocular Inserts 
Impregnated with antibiotics for trachoma therapy applications. In in 
vitro experiments, they found that the release rate of a drug with 
relatively high solubility was Influenced by the solubility of drug in 
water. A drug with low solubility in water had a constant release 
pattern when the water content of the hydrogel insert was more than 30%. 
In this case, the stirring of the solution Increased the release rate. 
However, for a drug with high solubility, the rate determining step of 
the release was the diffusion of the drug within the gel. Consequently, 
a small change of water content of the hydrogel affected the release 
rate, although the stirring of the solution had little effect. The drug 
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release rate was a little higher in vivo than in vitro for the low 
solubility drug case. 
Ocular inserts for the treatment of IBK 
Several ocular inserts were suggested as the treatment system for 
providing pinkeye therapy for cattle. Hawley (1954) developed a 
terramycin®eye pellet that provided therapeutic concentrations of 
terramycin®.^  The pellet consisted of 5 mg of oxytetracycline 
hydrochloride in crystalline form, polymyxin B sulfate (10,000 units) and 
tetracaine hydrochloride (1 mg) as the anesthetic. The pellet was 7/32 
inch in diameter and was tableted in order to adhere to the eyeball 
without producing irritation. Each pellet was implanted by placing it at 
the bottom of the lower eyelid and then was released to allow the lower 
eyelid to fold back to the normal position. Efficacy studies were 
conducted for a total of 1121 cattle that were treated for IBK using the 
eye pellets. Early infections were cured (more than 90% success) by 
using a single implantation of one pellet, whereas severe infections 
often required additional implantations. From measurements performed on 
tear samples of 16 Hereford cattle, antibiotic activity was observed for 
31 hours following implantation (concentration level of 0.67 (Xg/cc 
measured by using a modified plate assay method). In safety tests to 
determine complete safety for use of the eye pellet, extreme dosages (25 
pellets per eye over 5 days period) showed no observable effect. 
Brand of oxytetracycline, Charles, Pfizer & Co., Inc. 
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Hughes and Pugh (1975) made a ring device for use in the bovine eye. 
They suggested that ring-shaped devices with an erodible matrix 
containing antibacterial agents could be used as a possible method for 
the treatment of XBK; however, they did not report any work on the actual 
use of therapeutic agents. The ring-shaped devices were fabricated from 
polyethylene, polyvinyl chloride, and nylon surgical tubing of various 
lengths. However, they did not determine the optimal size of 
cross-sections and the range in sizes required for the application of 
such ring devices for cattle of various ages. In 1980, they patented 
this as an ocular ring device for sustained drug release, although they 
never conducted any tests using drug release (Hughes and Pugh, 1980). 
The retention characteristics of these devices will be described in a 
subsequent section on retention. 
Theodorakis et al. (1983) have prepared an ocular insert which was 
made from a composite of chloramphenicol sodium succinate (CASS) with 
polylactic acid (PLA). CASS was released from this Insert, and CASS may 
be used for the treatment of IBK. This device was designed to attach 
onto the third eyelid of cattle and rabbits. The insert included a disk 
impregnated with CASS in controlled-release form and a spear of 
bioerodable PLA for attachment of insert into the third eyelid. The 
insert was retained in the eye at least four days. The release levels of 
CASS from the composite in an in vitro test achieved therapeutic levels 
of CASS during a period of seven days in the eyes of four rabbits. 
However, they did not test the release of CASS in the bovine eye. This 
device was patented by Brightman and Theodorakis (1984) as a 
17 
biodegradable ocular lasert for controlled delivery of ophthalmic 
medication. 
Slatter et al. (1982a) described the release of gentamlcla from 
Insoluble collagen films as an application for the therapy of IBK for 
bovine eyes. In their research, a good correlation between In vitro and 
In vivo drug release data In bovine eyes was found. Concentrations In 
the precorneal film during the 24 hours after Insertion were still at the 
minimum Inhibitory concentration level for gentamlcln for ^  bovls 
control. They proposed that this type of Insert was suitable as a 
sustained drug delivery system for the treatment of IBK. In further 
research, Punch et al. (1985) have compared the release of gentamlcln 
from a soluble and an insoluble collagen film impregnated with 
gentamlcln. They found succlnylated collagen films could release higher 
levels of gentamlcln than the Insoluble films, and maintain the 
therapeutic levels (0.37 flg/ml in vitro tests) necessary to treat 
Moraxella bovls, but only for 24 hours. The Inserts showed no irritation 
reaction when initially placed in the eye, and were well tolerated by the 
cow in contrast to their previous study using hydrophlllc contact lenses 
(Slatter et al., 1982b) in which corneal edema developed in some cattle 
immediately following insertion. 
Punch et al. (1987a) examined the release rate of procaine 
penicillin, erythromycin and erythromycin estolate from soluble and 
insoluble collagen films in an in vitro test to develop an ocular insert 
for the treatment of IBK. The ring-shaped, flat collagen inserts had an 
average width of 10 mm and an internal diameter of 43 mm. Procaine 
penicillin, an insoluble antibiotic, was released rapidly from the 
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soluble collagen films, but the inserts failed to produce a sustained 
antibiotic release. Erythromycin and erythromycin estolate from the 
insoluble films were released rapidly within a short period, while the 
drug release from the soluble films was sustained for a longer period at 
a much higher rate. However, they failed to design an ocular insert 
suitable for use in the conjunctival sacs of cattle due to the lack of 
rigidiQr and flexibility of their insert material. Ring inserts tore and 
swelled after insertion time and this led to poor retention of ocular 
inserts in the eye. 
In vitro studies of hydrogel ocular inserts for IBK 
A ring-shaped ocular insert for IBK was made for in vitro testing 
(Ryoo, 1986). Tylosin tartrate (which is soluble in water, nontoxic and 
nonirritating to the eye) was used as the drug. Ring-shaped polyvinyl 
chloride tubing was dip-coated in a drug-hydrogel solution. The hydrogel 
chosen was a copolymer of hydroxyethyl methacrylate (HEMA) and methyl 
methacrylate (MM). The hydrogel matrix material was shown to be capable 
of sustained drug release for a desirable period of several days. 
In in vitro drug release experiments, all ring devices (24 devices) 
showed relatively high release rates (48 - 3631 jUlg/hr) in the initial 
release period (measured at 2 days). The release profile decreased 
rapidly after 2 days. After 9 days, all of the ring devices provided a 
release rate of 3 - 7 pg/hr. These values were above that estimated drug 
release rate (about 1.2 jmg/hr) necessary for treating IBK. After 
insertion into the bovine eyes, the eyes did not exhibit any inflammatory 
reaction during week long tests. 
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Physical characteristics of ring devices were observed before and 
after an experiment by using scanning electron microscopy (SEM) (Greer 
and Ryoo, 1987). The SEM results showed that a hydrogel coating surface 
was smooth both before and after a 9-day In vitro experiment (up to 
10,000 X magnification). Also, the ring devices had appropriate rigid 
and flexual properties necessary for long term retention (over 7 days). 
Retention Studies for Ring-shaped Ocular Inserts 
A good ocular insert must be designed for prolonged retention in the 
eyes of cattle. In addition, the device should be easy to insert and 
should not induce tissue reaction. Therefore, the mechanical properties 
and the selection of device materials are important factors in the 
retention study. 
A ring-shape ocular insert was chosen as the configuration suitable 
for use in the bovine eye by Hughes and Pugh (1975). Even though they 
did not report any drug incorporation or drug release experiments for 
bovine eye experiments, they were first to test the feasibility of using 
plastic tubular rings in cattle eyes. They evaluated ring devices 
fabricated from intradermic polyethylene (outside diameter: 1.092 and 
1.575 mm), medical grade polyvinyl chloride (outside diameter: 0.9144, 
1.651, 2.82 and 3.607 mm), and nylon (16, 18 and 20 gauge) tubing. They 
used a total of 20 dairy calves of an age range of 4 to 10 months. The 
first 5 ring sizes were made in 10 mm-increments, beginning at 99 mm 
length of tubing (31.5 - 44.3 mm in diameter). The second group was made 
in 3 mm-increments, beginning at 120 mm and ending at 148 mm (38.2 - 42.0 
mm in diameter). Local eye reaction to the ring devices was minimal, and 
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ranged from an Increased tear rate initially, to an increased mucous 
secretion after a ring was emplaced. They only studied a total of 15 
rings; thus the retention Information was very limited. Among these 
data, 8 rings were ejected within 2 days and one ring was retained for 
just 2 days. Six rings were retained for at least 6 days. One ring was 
retained in a calf eye for 19 deys. They emphasized that the retention 
of devices In the bovine eye was dependent on the ring size. They 
recommended a range of 135 to 140 mm in circumference as a result of 
their study. Also, the authors reported that the long retention of the 
single ring device was made possible by having the ring size with a 
circumference smaller than that of the conjunctival sac, but larger than 
that of the globe of the eye. If a ring is too large or too small, the 
ring tends to be forced out and is easy to distort. If the size and 
material criteria are met, the ring devices might be uniquely suited for 
use in the bovine eye. They claimed that the material for ring devices 
should be rigid enough to retain its ring shape, but should be flexible 
enough to conform to the shape of the conjunctival sac. However, they 
did not try to correlate the eye size and the ring size. 
Ryoo (1986) in preliminary in vivo insertion tests of polyvinyl 
chloride (PVC) ring devices used six ring devices to check drug release 
rates, retention conditions, and level of any eye irritation (if 
present). Five of the six cattle dislodged a PVC ring device within 
minutes of Insertion. The cause of removal was weak joining of the ring 
tubing and concerted movements of the lower and third eyelid. Only one 
of six ring devices was retained for more than 1 week. In order to use 
ring devices for additional retention tests, the mechanical properties of 
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ring devices were Improved by using the following techniques. First, 
ring devices were preconditioned in a saline solution for about 2-3 
hours, so that they were soft and pliable prior to insertion, and thus 
less susceptible to cracking. The wet devices had better flexibility 
than the dry ones. Also, hydrogel-coated tubes were connected by a piece 
(about 1 cm of length) of a small diameter PVC tube using a new adhesive 
based on a mixture of copolymer and tetrahydrofuran/polyvinyl chloride 
solution immediately after dip coating. These ring devices had stronger 
joints compared with those used in the initial in vivo tests and the 
retention characteristics were improved. 
Punch et al. (1987b) tried to determine the optimal size of ring 
devices for insertion into the conjunctival sac of adult cattle. They 
tested two hypotheses for the determination of the ring size: (1) the 
use of a 165 mm length for all adult cattle (6 mm diameter tubing) as a 
standard-sized ring and (2) a particular correlation between the measured 
palpebral aperture (using a vernier caliper) and the size of the retained 
ring. In order to calculate the tube length associated with hypothesis 
(2) for each cow, three equations were applied; Lja(Dj+R)7r , Lj=(Dj.)7r , 
and L^ (D^ +&/2)ir , where is the length of tubing, D^ . is the internal 
diameter of tubing, and R is tubing diameter. Here, «as assumed to be 
equivalent to the size of the measured palpebral aperture. They used 6 
mm and 4 mm polyvinyl tubing, and 2 mm nylon tubing as proposed by Hughes 
and Pugh (1975). They inserted the ring into the upper conjunctival 
fornix and then positioned the ring into the lower conjunctival sac. 
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Also, they looked for a correlation of the physical dimensions of 
the conjunctival sac with total body weight. The mean value (± standard 
deviation, SD) of palpebral aperture size and the body weight was 43.4 ± 
3.0 mm and 426 ± 74 kg, respectively. The experimental data did not give 
a strong correlation for the two factors. 
They used a total of 154 cattle (36 for the 6 mm diameter PVC, 48 
for the 4 mm diameter PVC, and 70 for the 2 mm diameter nylon tubing). 
The rings were inserted in either the left or right eye. If the rings 
produced severe eye irritation, they were removed, and then the eye was 
treated. The majority of rings which were not retained in the eye during 
their desired testing period fell out in less than 24 hours. The overall 
success rate of retention varied between 11 % and 75 %. The 6 mm PVC 
tubing had lower retention rates (11 - 44 %) than those of smaller 
tubings (28 - 75% for 4 mm PVC and 50 - 60% for 2 mm nylon) because the 
large diameter rings were removed due to side effects. A mean retention 
time for a satisfactory size of ring was seen to occur about 6 days, 
while too large and too small sized rings had retention time of about 3 -
4 days. The larger a ring was, the more side effects such as eye 
irritation occurred. If there was a serious irritation, the 
investigators removed the ring from the eye. They noticed that these 
results might be due to either a poor correlation between the 
conjunctival sac size and palpebral aperture size in cattle or from the 
application of inappropriate equations used for determining the suitable 
ring size. The use of the palpebral aperture measurement to select the 
ring size for cattle was not completely successful. 
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Reproduction of IBK 
Several predisposing factors are considered necessary for ^  bovis 
to cause disease. A major factor is ultraviolet (UV) radiation, the 
annual peak of which is positively correlated with the peak incidence of 
IBK in the field. Exposure to excess amounts of biologically effective 
sunlight damages bovine eyes and increases their susceptibility to 
M. bovis. Experimentally, IBK can be produced by direct exposure of the 
eye to UV light followed by the instillation of M. bovis (Hughes et al., 
1965; 1968). 
Many of the organisms related to IBK cause a conjunctivitis rather 
than keratoconjunctivitis, e.g., adenovirus (Wilcox, 1970), infectious 
bovine rhinotracheitis(IBR) virus (Fugh et al., 1970) and Mycoplasma 
bovoculi (Rosenbusch and Knudtson, 1980). Enhancement of M. bovis 
pathogenicity has also been found by some research works to be induced by 
prior infection with M. bovoculi (Friis and Pedersen, 1979, Rosenbusch, 
1983), an organism which by itself caused mild conjunctivitis when 
instilled into the eye of calves (Rosenbusch and Knudtson, 1980). 
However, other researchers have failed to reproduce any clinical signs of 
IBK by instillation of M. bovoculi into the conjunctival sac (Langford 
and Dorward, 1969). 
Ultraviolet radiation method 
In 1965, Hughes et al. first reported that ultraviolet radiation 
exposure has an enhancing effect in M. bovis infection of bovine eye. 
They concluded the use of ultraviolet light makes possible the study of 
the disease under controlled conditions at any time of year. M. bovis 
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infection caused severe clinical signs of keratoconjunctivitis with dally 
doses of middle ultraviolet light (2800 to 3200 Â) from a sunlamp. They 
also determined the effects of length of irradiation by sunlamp each day 
in their following work (1968). They found that the optimal results 
without gross corneal damages were obtained by irradiating the eyes twice 
for 10 minutes, 24 hours apart, with the UV source placed at a distance 
of 61 cm from the eyes. After the 2nd irradiation, instillation of 
M. bovls resulted in eye infections and corneal opacities in all calves. 
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STATEMENT OF THE PROBLEM 
Nature of the Problem 
Infectious bovine keratoconjunctivitis (IBK) Is an ocular disease In 
cattle and Is commonly called pinkeye. IBK Is a disease occurring 
perennially in all areas where cattle are raised. Also, IBK is extremely 
contagious and once an Infected animal is found in a herd, pinkeye may 
spread to most members of a herd within weeks. It is rarely fatal, but 
it may result in a major economic loss associated with weight loss in 
beef herds and with a reduction in milk production in dairy herds. 
The present treatment method consists of topical applications of 
antibiotics and sulfonamide as eye drops, ointments, or powders for a 
period of five to seven days. However, these methods are not useful to 
maintain therapeutic levels of drug in the eye and therefore repeated 
applications are necessary. As an alternative method to treat ocular 
Infections, controlled release systems have been studied in order to 
release drug continuously. Several ^ pes of ocular insert devices 
(Hauley, 1954; Theodorakis et al., 1983; Punch et al., 1985) were 
suggested as the way to treat pinkeye. However, none of these inserts 
maintained therapeutic levels of drug release for the desired period of 
at least 7 days. Also, these ocular inserts exhibited poor retention 
characteristics due to improper rigidity or flexibility properties. 
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Approach to the Problem 
Hughes and Pugh (1975; 1980) used ring-shaped plastic tubes in the 
bovine eye in preliminary retention tests. The tubular inserts did not 
contain any drugs. They first attempted to determine the feasibility of 
designing the ring devices (especially, the size and shape) based on 
bovine eye structures. They used three inert polymer materials 
(polyethylene, polyvinyl chloride (PVG), and nylon surgical tubing) as 
experimental devices. However, the test was very limited because only 
the retention data for a total of 15 rings were reported. Also, it was 
not clear how long the particular materials were retained. They 
emphasized the physical characteristics of different tubing materials 
rather than the detailed local reaction associated with each tubing 
material. Apparently, polyvinyl tubing was more satisfactory than the 
others. They reported that the ring devices exhibited slight adverse 
reactions in the eyes. They did not follow this up. Related research 
has been conducted by only a few other investigators (Greer and Ryoo, 
1987; Punch et al., 1987b). 
A controlled ring-shaped device releasing tylosin tartrate 
(contained In hydrogel coatings on PVC tubes) has been studied in a 
series of in vitro experiments (Ryoo, 1986). All of three types of 
polymer tubes (silicone rubber. Teflon®and polyvinyl chloride) were 
fabricated using a hydrogel coating. The hydrogel did not cause any eye 
irritation and was shown to be capable of sustaining the drug release of 
the antibiotic for the required period of interest for IBK treatment 
applications. The physical characteristics of three tubings were 
compared and evaluated to make a suitable ring device for use in in vivo 
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tests. Among three ring devices, an ocular Insert using polyvinyl 
chloride tubing was chosen as the best device material because it had 
good flexibility, was easy to fabricate in the form of a ring device, was 
low in cost, and had good mechanical properties. Also, in these in vitro 
experiments, drug release rates monitored (in vitro experiments using an 
artificial tear solution) were observed to be above the therapeutic level 
necessary for suppressing the bacterium (Moraxella bovis) for at least 9 
days. 
On the basis of these promising release results, the present work 
evaluated the effectiveness of hydrogel ocular inserts in in vivo 
experiments of two types: (1) the use of ring shaped drug release 
devices in treating bovine Infected eyes and (2) retention studies of the 
devices. Three types of ring devices were of interest: (1) medicated 
ring devices for treating Infected eyes (antibiotic dissolved in the 
hydrogel coating on PVC rings), (2) non-medicated ring devices for use as 
controls in the study using Infected animals (hydrogel coating on PVC 
rings), and (3) non-medicated ring devices for retention studies using 
healthy beef and dairy cattle (hydrogel coating on PVC rings). 
In the infection study, ten calves were used (two or three calves 
were studied during a test period as a matter of convenience). All eyes 
of these animals were preconditioned using ultraviolet radiation, and 
followed by instillation of a bovis inoculum. After inoculation, the 
build-up of the number of bacteria in the eyes was monitored by sampling 
tears from infected eyes with swabs (every two days). Also, during the 
progress of the Infection, each eye was examined visually on a dally 
basis. Seven days after instilling the bacteria, both infected eyes 
received a ring device Insert: one eye was treated (I.e., received a 
medicated ring) and the other eye was a control (I.e., received a 
non-medicated ring). The eyelids of eight calves were sutured In order 
to Insure that the treated rings would stay In the eyes during the 
experiment. The eyelids of two other calves were not sutured In order to 
check whether or not rings would be retained during the experiment 
period. After ring Insertion, tear samples were collected every two days 
and the number of bacteria in both eyes were measured for the 7 day 
treatment portion of the experiments. The observation of the decrease in 
number of bacteria over time indicated the effectiveness of devices. 
The retention tests were done in two stages: the first stage was to 
determine a size criterion that could subsequently be tested for ensuring 
that selected sized rings can stay in the eye for 7 days with a high 
degree of confidence, and the second stage was the test of the size 
criteria for a large group of animals. To determine the size criteria of 
ring devices, as a preliminary retention test, several ring sizes were 
applied to the eyes of cattle of various ages. From these retention 
data, the relationship between the ring size and the measured eye size 
was determined. From these initial data, the range of ring sizes used 
for cattle of different ages (and weights) and the associated differences 
in eye sizes provided Information for developing an empirical expression 
to aid in ring size selection for a particular eye size of a cow. This 
criterion was applied to another group of cattle, it was analyzed 
statistically, and it formed the basis for stating an optimal size 
criterion for ring selection. This second stage was done to check the 
reliability of this optimal criterion. The physical characteristics of 
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the rings were also examined to check the condition of a ring device 
after in vivo retention studies. 
Significance of the Research 
This in vivo experiment is the first test of hydrogel ocular Inserts 
containing an antibiotic for use in controlling pinkeye infections in 
cattle in which device release characteristics are of sufficient duration 
and magnitude to address the problem. 
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METHODS AND MATERIALS 
The Methods and Materials chapter Is divided into four major parts: 
(1) fabrication of hydrogel ocular inserts, (2) in vivo drug release test 
of ocular inserts, (3) in vivo experiments for quantitative analysis of 
IBK and (4) in vivo experiments for retention of ocular Inserts. In 
order to make ocular inserts for in vivo experiments, a copolymer coating 
material was produced, an antibiotic was added to a solution of the 
copolymer, and then ocular inserts were fabricated by a dip coating 
method. These hydrogel ocular Inserts were used for the evaluation of 
the effectiveness of polymeric drug release inserts for the treatment of 
IBK. In general, both eyes of a calf were infected and then one eye 
received a medicated ring and one eye received a non-medicated (control) 
ring. The number of bacteria in both eyes was monitored as a function of 
time using quantitative bacteriological analyses of tear samples. Also, 
clinical examinations of both eyes were performed on a daily basis. By 
comparison, in the in vivo retention test, non-medicated ocular inserts 
were used to evaluate whether or not the optimal size criterion (for the 
proper size estimation of a ring device) was suitable. 
Fabrication of Hydrogel Ocular Inserts 
Production of copolymer (hydrogel) 
The methyl methacrylate (MMA) and hydroxyethyl methacrylate (HEMA) 
copolymer was made in a batch process. The following materials were 
added in the order listed to a one-liter Erlenmeyer flask: 570 ml of 
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absolute etbanol, 380 ml of type-one water, 6.1 ml of HEMA^ , 46.6 ml of 
0.25 gm of reagent grade sodium persulfate and 0.125 gm of reagent 
grade potassium persulfate to provide a MMA:HEMA copolymer on a 90:10 
molar basis. The flask was sealed with a rubber stopper and the contents 
were bubbled vigorously with nitrogen for 30 minutes (to remove oxygen 
from the solution). After thlr^  minutes» the nitrogen pressure was 
adjusted to a slow continuous bubbling throughout the ten day 
copolymerization period. The reaction was carried out at room 
temperature. On the tenth day, the 90:10 copolymer was present in the 
form of a white sticky precipitate. The solution containing the 
copolymer was added to three liters of water. The liquid was filtered 
through Whatman 1-quantitatlve filter paper in a Buchner funnel by using 
a vacuum. Each time the funnel was full of precipitate, the precipitate 
was washed four times with 25 ml of water, and was placed into a glass 
container for drying. This container was covered with filter paper which 
prevented contaminants from entering during the drying period. The 
copolymer was dried in an oven at 50°C for five days under a vacuum (25 
in. Hg). 
2 
?olysciences Inc., Lot #2-2405, Ophthalmic Grade, Washington, PA. 
3 
Aldrlch Chemical Co. Inc., Lot #041557, Milwaukee, WI. 
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Fabrication of ocular Inser t 
Preparation of coating material Monolithic devices used In this 
study were made by dlp-coatlng a polyvinyl chloride tube. The tube was 
dipped Into a drug/copolymer mixture (for a medicated ring) or copolymer 
(for a non-medicated ring) and dried; this process was repeated several 
times to build up a surface layer of coating materials. 
In order to reduce the time required for a complete dissolution of 
the copolymer In the solvent, the copolymer particles were crushed or 
ground. For the 90:10 copolymer, à ceramic crucible was used to grind 
the hard, brittle copolymer. One gram of the copolymer powder was added 
to 20 ml of dimethyl formamide, mixed, and the mixture was heated at 50^ 0 
for six hours to dissolve the polymer. Then, the copolymer/drug mixture 
was made by first cooling the solution to room temperature and then 0.5 
gram of tylosln tartrate was dissolved In the copolymer/solvent mixture. 
The finished copolymer/drug mixture became a yellow, viscous solution. 
The non-medicated rings for the retention tests and for control rings in 
the Infected eye tests were made from the mixture of 1.5 gram of 
copolymer and 20 ml of dimethyl formamlde. 
Preparation of mandrels All the devices were fabricated by 
dip-coating ring shaped plastic tubes. These mandrels were made by 
Inserting a stainless steel wire through a piece of polyvinyl chloride 
tubing* and wrapping the tubing (containing the wire) around a cylinder 
form of the correct diameter (35 - 65 mm). All mandrels were weighed 
Beeton, Dickinson and Co., Transparent/radlopaque type. 
Sizes: 0.034"(I.D.)x0.046"(O.D.) and 0.020"(I.D.) x 0.036"(O.D.), 
Rutherford, NJ. 
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before and after coating to establish the weight of the copolyner-drug or 
copolymer coating, and the drug loading of a ring device was calculated 
on the basis of the original drug to copolymer ratio. 
Dlp-coatlng process A mandrel was dipped Into the copolymer/drug 
mixture or copolymer mixture and was bung In a drying chamber containing 
nitrogen to make a uniform coating. The moisture In the air can 
otherwise cause the copolymer layer to swell and become porous. Each 
coat deposited 10-15 mg of copolymer/drug or copolymer mixture, so nine 
to fifteen coats of solution were required to deposit the desired amounts 
of drug and copolymer onto the devices. 
Production of finished ring device After drying dip coated ring 
devices in the desiccator for 3 days, the weight of ring devices was 
measured to check the loading amounts of coatings. Then, ring devices 
were left in the moist condition for 2 hours. After this preconditioning 
period, rings became flexible enough to remove wires from their mandrels. 
Both sides of a polymer ring device were then joined using a short piece 
of a thin polyvinyl chloride connecting tube (0.020" I.D. x 0.036" 
O.D.). A small bead of an adhesive such as a mixture of copolymer/drug 
was used to connect the tube sides. The tips of a polyvinyl chloride 
ring device widened slightly compared to the rest of the tubing, which 
made the smaller diameter joint easy to insert into a dried ring device. 
Each medicated ring device contained about 30 milligrams of tylosln 
tartrate in 100 mg of hydrogel (10:90 mole % copolymer of HEMA:MMA). A 
non-medicated ring device contained about 150 mg of hydrogel. Typical 
ring diameters were within the range of 30 to 60 millimeters. This 
provided a number of rings for use with different size animals. 
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In vivo Drug Release Test of Ocular Inserts 
Sampling me thod from eyes 
A cotton-tipped swab was used to absorb tear fluid at the medial 
canthus area of the eye. A swab with a wood stick was retained for a 
while at the medial canthus to obtain sufficient tears (about 0.2 - 0.3 
ml) so as to be able to analyze for drug release amounts. Then, the tear 
fluid in a swab was withdrawn from the swab by suctioning with an 1 ml 
tuberculin syringe with a 27 gauge needle. 
Portions of this sample were spotted directly on the thin layer 
chromatography (TLC) plate in the field or at the laboratory. Some 
samples which contained small amounts of drug required multiple spotting 
to yield enough drug to make a visible spot. 
TLC analysis of drug release from ocular insert 
The drug concentration of tear samples was analyzed by using a TLC 
technique. Four known concentrations of tylosin tartrate (0.5, 1.0, 2.0 
and 4.0 ug/2.5 fU) were used as the standard samples. The plate spotted 
by standard and tear samples (2.5 pi per each sample) was developed in 
85% methanol - 15% water and then was air-dried completely. A compact 
4-watt ultraviolet lamp (UVGL-25) was used to insure that the 
concentration level was within the range of standards spotted on the same 
plate (based on the relative size of spots viewed against a fluorescent 
plate background). Then, a TLC plate was sprayed with a 10% Hggo^  - 90% 
methanol solution, and was heated for 5 min at 100°C. The plate, where 
the spots could be visualized, was analyzed using a Rontes Fiber Optics 
Scanner (model 800) and a computer analysis system. The computer 
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analysis system was developed to characterize the amount of drug release 
from the TCL plate on which tear samples were spotted. This system 
consisted of two parts: hardware and software. Hardware Included a 
personal computer (IBM PC-AT or Zenith 248) and data acquisition system 
(Keithley system 570). Software was composed of two programs: data 
acquisition system and data processing system for quantitating the drug 
amount released from ocular Inserts to eyes. Using this computer 
analysis system (Ryoo et al., 1989), the peak data were analyzed 
automatically within about 3 min for 20 samples/plate and saved on a 
floppy disk for post-run analysis. 
In vivo Experiments for Quantitative Analysis of IBK 
In order to reproduce the disease successfully, an ultraviolet 
radiation method was used in conjunction with the M. bovis infection. 
Calves were studied in groups of 2 or 3 animals. A summary of 
experimental procedures for each animal group is given in Table 3. 
Ultraviolet radiation method 
Preparation of antibiotic disks for antibiotic susceptibility 
test Before selecting an antibiotic for the treatment of pinkeye in 
cattle, an antibiotic susceptibility test was done for three useful 
antibiotics. In order to make antibiotic disks, 2 mg/ml solution of 
streptomycin, of ampicillin and of tylosin were first prepared and 
filter-sterilized. Ten microliters of each solution was added to each 
paper disk. Then, all disks containing each antibiotic were dried under 
a sterile air-flow to prevent any contamination. Disks containing 20 Jttg 
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TABLE 3. A summary of experimental procedures for each animal group 
Group Animal Experimental Procedures 
No. No. infection treatment post-treatment 
method insert type suture 
I 149L Ultraviolet medicated yes Treat with 
149R radiation non-medicated yes oxytetracycline 
injection® 
150L medicated yes 
150R tl non-medicated yes 
II 152L It non-medicated yes apply medicated 
152R medicated yes ocular insert 
to control eyes 
153L tl non-medicated yes and inject 
153R . medicated yes oxy te tracycline 
solution 
154L tl medicated yes 
154R non-medicated yes 
III 8002L It non-medicated yes 
8002R medicated yes 
8007L It medicated yes the same as 
8007R non-medicated yes above 
8013L It medicated yes 
8013R non-medicated yes 
IV 8031L tl non-medicated no Inject 0.7 ml 
8031R medicated no of penicillin-
dihydros trep tomycin 
8032L non-medicated no -dexame thasone^  
8032R medicated no subconj une tival 
\iquainycln®(LA-200)» Pfizer, New York, NY 
A^zimycii^  Schering, Union, NJ 
of each antibiotic were stored in a sterile tube at -20°C in order to use 
them at a later time on a lawn of ^  bovis. 
Antibiotic susceptibility tests A lawn of bovis was prepared 
by the same procedures as described in the following section on 
preparation of M. bovis seed (bacterial cultures). Then, the antibiotic 
disks were placed on the M. bovis lawn on a blood agar plate (BAP).5 Each 
disk containing a different antibiotic was tested. The plates were 
stored in the incubator for 24 hrs at 37°C in 10% COg. Then, they were 
stored at room temperature for 24 hrs. The diameter of zones of growth 
inhibition associated with the effect of each antibiotic was measured to 
evaluate the sensitivity of the antibiotic. The wider the diameter of a 
zone, the better the sensitivity of the bacteria to the antibiotic. 
Animals Ten Holstein calves (groups I, II, III and IV) were 
used. They had not been previously exposed to IBK and were raised on 
antibiotic-free calf feed. The age of the calves varied from 3 to 6 
months. They were kept indoors in individual isolation units, which 
excluded sunlight and flies. The quarters were mechanically ventilated 
with filtered air. 
Preliminary microbiological examination for selected 
animals Tear samples from each calf were collected from the 
conjunctiva area by using a sterile cotton swab in order to check for the 
presence of any virus or bacteria growth (including H. bovis) in the eye. 
Blood agar plates (BAP) are made with blood agar base (Difco, 
Detroit, MI) with 5% defibrinated bovine blood. Blood should not be kept 
refrigerated more than 21 days at the time of use. 
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This swab was streaked on a blood agar plate (BAP) and spread using a 
sterile wire. The blood agar plate was stored in the 37°C incubator. 
After 24 hrs, the BAP was read to check whether or not any microorganisms 
had grown. If any gram-negative bacteria appeared, the animal was 
treated with approximately 700 mg of antibiotic ointment^  containing 10 
mg of chloramphenicol, 10,000 units of polymycin B, and 5 mg of 
hydrocortisone acetate In each gram. After the treatment with antibiotic 
ointment, samples were again collected within 3 days to make sure the eye 
was bacteria-free. 
Bacterial cultures An isolate of M. bovis (118F) was obtained 
from a herd with severe IBK (Rosenbusch, 1983; Ostle and Rosenbusch, 
1986). The strain grew with a "smooth corroding" type of colonial 
morphology (Pedersen et al., 1972) and was piliated as shown by electron 
microscopy (Rosenbusch and Knudtson, 1980). Strain 118F of Moraxella 
bovis grown as a 5th passage was used as a seed. One cryotube containing 
the ^  bovis strain stored in a -70°C freezer, was defrosted in warm 
water. A starter BAP was inoculated by streaking M. bovis using a swab, 
and the starter was diluted with a flamed wire loop. This plate was 
labeled and put into the sealed Bio-Bag "^ system^  to provide a 
microaerophilic atmosphere (10% COg). Then, the sealed plate was 
incubated for 24 hrs in the 37°C incubator. The plate was removed from 
O^phthocor^  Parke-Davis, Morris Plains, NJ. 
B^io-Bag'"^ 'Type Cfj is a disposable, individual environmental 
chamber and a CO^  gas generator. 
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the Incubator and left at room temperature for 24 brs, and then it was 
observed for contamination among the ^  bovis colonies present. 
First ultraviolet irradiation and Preparation of M. bovis 
inoculum Two sunlamps^  were used as sources of ultraviolet radiation. 
In order to radiate the eyes with ultraviolet radiation from the 
sunlamps, each animal was held in a portable cattle chute. Each calf was 
tied to the cattle chute in order to restrict head movements. The lamp 
was positioned so that its flat surface was approximately parallel to the 
plane of the cornea, and the eye of the animal was in the center of the 
beam. Each eye was irradiated for 10 min at 61 cm. After the UV 
irradiation, the necessary number of blood agar plates for M. bovis 
inoculation was prepared prior to use the next day. Half of the (about 
30) ^  bovis colonies (smooth corroding hemolytic ^ pe) on the plate were 
picked by using a sterile cotton swab. Then, the bacteria on the cotton 
swab were resuspended in 1.0 ml - 1.5 ml of 10% MgCl^  solution and 0.1 ml 
of this suspension was spread on each blood agar plate with a sterile 
bent Pasteur pipette. The number of necessary plates was determined by 
the number of experimental animals (usually, twice as many as the number 
of animals). These plates were incubated for 22 hrs in 10% COg at 37°C. 
Second ultraviolet irradiation and inoculation with M. bovis 
inoculum One day after the first irradiation, a second irradiation 
was done using the same procedure as the first irradiation. After the 
second irradiation, a M. bovis inoculum was prepared from the inoculated 
O 
General Electric Co., Model RSK6, Nela Park, Cleveland, OH; The 
wavelength range of 2800 - 3200 Â is of interest. 
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blood agar plates. All bacteria from each plate were harvested and 
suspended in 2 ml of cold gram-negative wash solution (O.SH sucrose, 5 mM 
phosphate buffer (pH 7), 50 mM MgCl^ , and 0.05% bovine serum albumin). 
When the bacteria were collected with a sterile cotton swab, the plate 
was carefully examined to see if any contaminants were present. If any 
contaminants appeared, another fresh plate was used. The total volume of 
the M. bovis suspension was determined by the number of animals used 
(approximately 1 ml/each eye). One tenth milliliter of the suspension 
was saved in a tube on ice for the titration of ^  bovis inoculum. An 
aliquot (1 ml for an eye) of M. bovis challenge was poured in a separate 
tube. All of the inoculums were kept on ice for 30 min. Each inoculum 
was instilled in each eye with a sterile cotton swab. About 0.5 ml of 
the inoculum was absorbed when a swab was soaked for a while. The 
reminder of the inoculum was then poured into the eye. 
Titration of M. bovis inoculum Xf ter the inoculum was ins tilled 
into the eye, 0.1 ml of the inoculum for titration was used to make 
titration plates. A ten-fold dilution was made by mixing 0.9 ml of 10% 
MgClg diluent with 0.1 ml of the inoculum. A second dilution was made by 
mixing 0.1 ml of first dilution with 0.9 ml of 10% MgClg diluent. By the 
same method, 4^ -6^ -8^ -10^ ** dilutions were made. One tenth milliliter 
of each dilution was spread on each BAP by a sterile bent Pasteur 
pipette. These titration plates were incubated for 24 hrs in 10% COg at 
37°C. The number of bovis colonies on a plate was counted. The titer 
was calculated in colony-forming units/ml (CFU/ml) of the original 
inoculum. The colony-forming units are defined as the number of 
separated colonies which were cultured on the blood agar plate. 
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Bacteriological évaluation After a ^  bovls challenge exposure, 
each tear sampling was repeated at 2 day-intervals for 17 days in group I 
and for 15 days in groups II, III and IV. A sterile cotton swab was used 
to collect a tear sample from each animal. A non-contaminated sample was 
obtained as follows. After eyelids were parted, a swab was put into the 
lower conjunctiva of eye and moved gently from side to side. Then, the 
swab was pulled out quickly without touching any outside portions of the 
eye. A centrifuge tube containing 3 ml of ice-cold gram-negative wash 
solution was prepared for receiving each tear sample. The swab was 
immersed in the gram-negative wash solution of the centrifuge tube and 
the tube was covered firmly with a cap to eliminate any contamination. 
All of the tubes containing a swab sample were agitated with a mixer.* 
The swab was pulled out with a sterile forceps after squeezing most of 
the fluid out of the swab into the tube. Later, all the tubes were spun 
at 12,000 revolutions per minute for 10 min at 4°C. The supernatant was 
poured out gently in order to keep the ^  bovis pellet on the inside of a 
tube. Three tenths milliliter of gram-negative wash or 10% MgClg 
solution was added to the tube containing the solid pellet. From this 
suspension (0.3 ml of undiluted sample), 0.1 ml of undiluted sample was 
added to a BAP. Then, another 0.1 ml of undiluted sample was added to 
2.9 ml of diluent (gram-negative wash or 10% MgClg solution) to make 1/30 
of dilution. Also, 1/3000 of dilution was made by mixing 0.1 ml of 1/30 
dilution with 9.9 ml of diluent. One tenth milliliter from diluted 
9 
Vortex-Genie, Scientific Industries, Inc., Model K-550-G, Bohemia, 
NY. 
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samples (1/30 and 1/3000) was also added to individually separated BAP. 
These samples represent 1/3, 1/90 and 1/9000 of the swab burden per eye, 
respectively. These samples were made in order to count the total number 
of M. bovis colonies accurately. A sterile bent Pasteur pipette was used 
for spreading samples on the plates. The plates were incubated for 24 
hrs at 37*C with 10% CO^ , and the number of ^  bovis colonies were read 
at 24 hrs. If many colonies (over 1,000 colonies) having a smooth 
corroding q^ pe of colony were observed, the total numbet of colonies was 
calculated by counting colonies in a fractional portion of a plate and 
multiplying this number by the appropriate factor to give the count for 
the whole plate. In order to distinguish the cultured colonies on the 
plates from other bacteria, the plates might also be read at 48 hrs, 
after the plates had been left at room temperature for an additional 24 
hrs. The results were expressed as colony forming units/swab or 
logigCFU/swab. 
Clinical examination Calves were designated as infected if 
M. bovis was recovered wice within four days after a challenge exposure 
(Pugh et al., 1982). All calves were observed once a day to check for 
clinical signs of pinkeye by visual examination. Any clinical signs of 
eye Irritation or obvious changes in tear flow rates were reported. The 
clinical condition was assessed on the basis of the progress of the 
disease. Five types of clinical observations of the disease were 
categorized: initial stage - photophobia, epiphora, blepharospasm; 
conjunctivitis, keratitis; central corneal ulceration; perforation of 
corneal ulcer, corneal scarring, blindness. 
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Treatment of ocular Inserts for Infected calves Seven days after 
M. bovls was Instilled Into the eye, one of two types of ocular inserts 
(medicated and non-medicated) was inserted into an infected eye to 
evaluate the effectiveness of a medicated ocular insert containing 
qrlosin tartrate. Both eyes were used, one as a treated eye and one as a 
control eye. A non-medicated ring was used for a control eye and a 
medicated ring was used for a treated eye. All the rings were selected 
on the basis of the eye size of each animal. They were preconditioned in 
Ringer's solution for an hour to Improve their flexibility (the hydrogel 
is stiff in the dry condition). After inserting the ocular Inserts, the 
eyelids of the calves in groups I, II, and III were sutured (three 
points). However, eyelids in group IV were not sutured in order to check 
whether or not rings were retained for at least a week when the eyelids 
were not sutured. 
Animals were sedated with xylazlne^  ^prior to suturing. Suturing 
was done for both eyes to Insure that no rings would be lost during this 
experiment. Before suturing the eyes containing a ring device, the 
eyelids were wiped clean. After Inserting a ring into each eye, both 
eyes were sutured according to the following method. First, the third 
eyelid was pulled over the eye and sutured to the upper eyelid. Then, 
the lower eyelid and upper eyelid were sutured together. In order to 
Improve the suturing closure, a double suture was done between the lower 
and upper eyelid. Figure 1 shows an example of the sutured eyelids. 
^^ Rompui^  Haver-Lockhart, Shawnee, KS. 
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FIGURE 1. An example of sutured eyelids 
After suturing, the closure condition of each eye was observed daily 
in order to see if it was necessary to resuture the eyelids. 
Bacteriological evaluation after ring insertion For the sutured 
eyes, tear sampling was quite difficult, because the eyelids were closed. 
Therefore, a cotton swab was carefully pushed into the eye without 
touching any outside parts of the eye. The swab was inserted deeply 
enough to reach to the conjunctival area, and the swab was moved gently 
side to side to get a good bacterial sample from the infected eye. Then, 
the swab was pulled out quickly and stored in the tube. However, if a 
swab was pulled out without taking a sufficient bacterial sample from the 
conjunctival area, the subsequent colony forming unit results could be 
non-representative (this might be an error source). Tear sampling and 
quantitative analyses were continued until the end of an experiment. 
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Removal of ocular Inserts from eyes About a week later, all 
sutures and ocular Inserts were removed in order to evaluate the 
condition of an eye and to take pictures, if necessary. Then, rings were 
gently washed with distilled water and were dried in a desiccator. After 
the rings were completely dry, rings were weighed so that an estimate of 
the total amount of drug (tylosin tartrate) released during the 
experiment period could be made. 
At the end of the observation period, and to cure the bovis 
infections of the control eyes, medicated ring devices were then inserted 
in place of the control (non-medicated) rings along with the immediate 
use of intramuscular injection of 9 ml of long-acting oxytetracycline^  ^
containing 200 mg of oxytetracycline/ml (oxytetracycline injection was 
used for group I and both for groups II aind III). 
For group IV, 0.7 ml of Azimycin was given as a subconjunctival 
injectionl2, containing 0.5 mg of dexamethasone, 10 mg of 
chlorpheniramine, 250 mg of dihydrostreptomycin and 200,000 units of 
penicillin G procaine in each ml (used in field cases of pinkeye) was 
injected into the subconjunctiva area. This was done in order to provide 
a basis to compare this treatment method with that of using a medicated 
ocular insert. 
^^ Liquamycii^  ^Pfizer Inc., New York, NY 
^^ Azimycin® Schering, Union, NJ. 
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In vivo Experiments for the Retention of Ocular Inserts 
In vivo retention tests were done by three steps: (1) using 
previously collected data from preliminary retention tests in which the 
ring size was selected randomly, a relationship between ring size and eye 
size (i.e., ring size minus eye size) and time of retention was 
formulated; (2) the optimal size criterion was determined by analyzing 
the retention data from the preliminary retention tests and from several 
calves used in the infection tests; (3) this optimal size criterion was 
evaluated by checking its usefulness for the sample proportion as well as 
for the population proportion. 
Animal sources 
All bovine data for the retention tests are shown in Tables 4 and 5. 
Animals in Table 4 were used for preliminary retention tests and for the 
determination of an optimal size criterion. Table 5 is a listing of the 
animal data for the retention tests using the optimal size criterion. 
The age of the animals was in the range of 3 months to 6 years. Most of 
animals were kept outdoors except the calves used in the infection tests. 
The weight of each animal was estimated in association with the age of 
each animal. The eye size of each animal was measured as the distance 
from medial can thus to lateral canthus. A ruler was used to measure the 
eye size (to the nearest 0.5 mm). 
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TABLE 4. Animal data for the preliminary retention tests and the 
determination of an optimal size criterion 
Animal Breed Age Weight Eye Animal* 
No. (lb) size (mm) source 
325 Hereford 3 yrs 650 45.0 VMRI 
329 2 yrs 650 44.0 
215 Hereford 5 yrs 800 46.0 VMRI 
310 3 yrs 800 47.0 
311 3 yrs 800 44.0 
345 cross-bred^ 7 months 360 (39.5)4 VMRI 
352 5 months 240 (37.0)d . 
750 cross-bredCg months 376 39.5 ASNF 
757 4 months 292 37.5 
149 Holsteln 6 months 420 39.5 VMRI 
150 6 months 320 36.5 
152 Holsteln 3-4 months 180 35.0 WLDF 
153 3-4 months 180 36.0 
154 3-4 months 180 36.0 
8002 Holsteln 4 months 200 37.0 VMRI 
8007 4 months 200 34.0 
8013 4 months 200 33.0 
8031 Holsteln 4 months 200 31.0 VMRI 
8032 4 months 200 32.0 
Animal sources are the following: VMRl - ISU Veterinary Medical 
Research Institute; ASNF - ISU Animal Science Beef Nutrition Farm; 
WLDF - Woodland Dairy Farm in Story City, Iowa. 
C^ross-bred: Angus and Hereford. 
c 
Cross-bred: Angus, Charolais and Simmental. 
M^easurement made after ring was Inserted. 
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TABLE S. Animal data foc the retention tests using the optimal size 
criterion 
Animal Breed* Age Weight Eye Animal 
No. (lb) size (mm) source 
203 cross-bred 6 yes 1421 42.0 ASNF 
922 9 yrs 1414 42.0 
205 6 yrs 1285 41.0 It 
232 6 yrs 1167 41.0 •t 
277 6 yrs 1312 41.0 II 
539 3 yrs 1300 41.0 II 
9559 Holstein 2 yrs 1210 43.0 DF 
9583 2 yrs 1100 44.0 
8768 6 yrs 1530 45.0 
9459 2 yrs 1170 43.0 II 
8973 5 yrs 1810 45.0 II 
9433 3 yrs 1180 41.0-42.0 II 
9598 2 yrs 1220 45.0 II 
9294 3 yrs 980 44.0 
9557 2 yrs 1150 46.0 
9606 2 yrs 1270 45.0 
9531 2 yrs 1220 44.0 
9275 4 yrs 1090 42.0 DF 
9588 2 yrs 1040 42.0 
9442 3 yrs 1260 41.5 
9465 3 yrs 1280 44.0 
9404 3 yrs 1190 41.0 
9507 3 yrs 1480 41.0 II 
9539 2 yrs 1200 40.0 II 
9236 4 yrs 1290 42.0 II 
9506 3 yrs 1100 42.0-43.0 II 
9045 5 yrs 1160 42.0-41.5 II 
8948 5 yrs 1630 43.5 II 
9002 5 yrs 1420 44.0 II 
9564 2 yrs 1240 46.0 DF 
9605 2 yrs 1120 40.5-41.0 II 
8828 6 yrs 1240 42.0 II 
9600 2 yrs 1430 42.0-43.0 II 
9338 3 yrs 1240 43.0 
9464 3 yrs 1200 43.5 
9478 3 yrs 1330 40.5 
9560 2 yrs 1200 40.0 
9354 3 yrs 1380 40.0 
C^ross-bred: Angus, Charolais and Simmental. 
A^nimal sources are the followings: ASNF - ISU Animal 
Science Beef Nutrition Farm; DF - ISU Dairy Farm. 
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Preliminary retention test 
The eye size was defined as the size measured from medial canthus to 
lateral canthus. Each eye was measured by using a ruler. The ring size 
was then determined by the measured eye size. In this test, the sizes of 
rings to be used were somewhat larger or smaller (within a few mm) than 
the eye size. Eleven cows were used and 28 rings were tested In the eyes 
(four of the eleven cows received more than two rings during the study). 
This test was used as the basis for obtaining a relationship between eye 
size and the optimal applied ring size. The difference of the optimal 
applied ring size and the measured eye size was compared to the observed 
retention times. From a plot of retention time (in days) versus the 
quantity, ring size minus eye size, certain sized rings were noted to 
stay in the eye for relatively long retention times when compared with 
the other cases for the 28 total comparisons. These data provided a 
basis for both selecting a ring size for additional retention tests and 
providing a data base for testing an empirical formula (developed in the 
next section) based on the bovine eye structure. 
Determination of the optlmal size criterion of a ring 
To exhibit long term retention, the size of a ring must be smaller 
than that of the conjunctiva and larger than the open area of the eye. 
If the exact size of conjunctiva or if the correlation of ring size with 
open area of the eye is known, the optimal size of ring can be easily 
obtained. However, in this case, both types of data were not available. 
Punch et al. (1987b) tried to get a correlation between the size of the 
open area of the eye and body weight. However, they did not find a 
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strong correlation. To approximate a solution, two assumptions were 
suggested: (1) the outside diameter of the conjunctiva Is 1.5 times 
larger than that of the measured palpebral aperture (horizontal length of 
eye opening); (2) the outside diameter of the conjunctiva Is twice the 
vertical length of the eye opening (the palpebral aperture Is 
approximately 0.7 times the height of the average vertical length (H) of 
the eye opening; therefore, the outside diameter of the conjunctiva Is 
1.4 times the horizontal length of the eye opening). 
Under these assumptions, the optimal size of rings was estimated. 
The first optimal diameter (D) of a ring was taken as 1.25 times the 
palpebral aperture, assuming the optimal size of a ring is to be the 
average of the outside diameter of conjunctiva (1.5 x L) and the 
palpebral aperture size (L). Thus, the optimal ring size would be (1.5L 
+ L)/2. Using the second assumption, since the average vertical length 
(H) of the open eye is approximately 0.7 times its palpebral length 
(measurements obtained from five animals in the present work), the second 
optimal size of the ring became 1.2 times the palpebral aperture. This 
is calculated as the average of the outside diameter of the conjunctiva 
and the palpebral aperture, (1.4L + L)/2, which equals 1.2L. Therefore, 
the optimal ring diameter was determined by a simple measurement of 
palpebral aperture. Among these two options, the approximation of 1.2 
times the palpebral aperture (D = 1.2 L) was selected as an empirical 
formula for estimating optimal ring size. This formula was used to 
determine the criterion of the range of optimal sizes. 
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PrecondltlOQlng of ocular laserts 
Each ring was preconditioned prior to use (to soften the copolymer 
coating). This was accomplished by placing each ring into a labeled 
petri dish (100 mm x 15 mm) containing Ringer's solution (20 ml). Rings 
were submerged for 1 - 2 hr before use. All of the ocular inserts were 
washed with Ringer's solution and distilled water twice three days before 
use. 
Insertion of ocular inserts 
The insertion was done using a fresh pair of examination gloves^  ^
for each animal. The cow's head and body were restrained in an outdoor 
isolation unit. Each eye was observed and its size determined before 
inserting a ring to insure that it was healthy and to select an 
appropriate size for the ring. The eye size of the animal was measured 
again after the ring insertion to make sure that the proper size of a 
ring device had been selected. 
The ring size for an eye was obtained from a ring selection chart 
based on the optimal ring size criterion (the chart was made as the 
values from the eye size x the factors, 1.18 to 1.23; these values are 
derived in the results section, retention tests using the optimal 
criterion for ring size). Then, a selected ring was inserted by holding 
the eyelids open while one side of ring was directed into the lower 
conjunctival fornix. The remaining half of the ring was then pushed 
under the upper conjunctival sac and was finally positioned onto the 
Beeton-Dickinson, Tru-touch medical gloves, single-use, vinyl, 
non-sterile, Rutherford, NJ. 
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outer surface of the third eyelid. After Inserting the ring device In 
the eye, the eye was observed 30 minutes later to make sure the device 
was properly retained and that no excessive tearing was observed. If the 
Inserted device fell out of the eye, a new ring device was Inserted at 
that time. The tearing rate and the extent of eye Irritation were 
observed once a day. If excessive tearing was seen, the ring was removed 
(It was likely to be relatively large within the sizing criterion). 
Generally, a portion of the ring's surface was visible near the medial 
canthus of an eye. This was helpful in judging whether or not a ring was 
seated in the eye properly. 
Removal of ocular Inserts 
Seven days after the Insertion, all of the retained ring devices 
were removed. Each eye was observed after removal of the ring in order 
to compare the appearance of the eye with initial eye appearance. Each 
ocular Insert was removed using a fresh pair of examination gloves. The 
eyes were also examined for a few days after ring removal in order to 
check for any side effects that might be related to the retention or 
removal. 
Physical examination of ocular Inserts after removal 
Each ring removed was stored in an empty petrl dish and was examined 
at a later time to check for any mechanical defects on the surface of the 
ring. A stereo-microscope was used to examine the surface condition of a 
ring. Any build-up of foreign material on the surface, any cracking or 
separation of the ring, or any change in the surface smoothness was 
observed. Also, the shape of the whole ring device and the Joint region 
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were examined. For rings removed from animals 757 and 750 ,  the surfaces 
were examined using scanning electron microscopy (SEM). These devices 
were immersed in 1% glutaraldehyde fixative for I hr and then 3% 
glutaraldehyde solution for 1 hr at 4^ C immediately after removal from 
the eyes. After that, the ring devices were stored in 200 ml of 70% 
acetone solution at 4°C for a day. Then, the rings were taken out of the 
acetone solution and dried for 2-3 minutes at ambient temperature. In 
order to prevent the formation of any cracks on the sample surface during 
the cutting process, the sample was cut into small pieces (5-7 mm) 
while wet using a stainless steel blade. After drying rings completely, 
the small pieces of rings (approximately 1 mm x 1mm) were mounted on a 
carbon stub prior to performing SEM studies. The specimens received a 
300 A coating of gold (Polaron £5100 sputter coater), and were then 
examined using a scanning electron microscope (JSH 840-A). 
Statistical evaluation of retention tests 
A two-tailed t-test was used to achieve two goals: (1) to test 
whether or not the normally distributed random sample supports the 
hypothesis that the value of jut^  (where is the average value for the 
sample observations) is (the average value taken for the test 
hypothesis), where ig some test value for and (2) to obtain the 
acceptable range of a specific ring size through this test. The 
preliminary retention data were used as the sample data and a hypothesis 
(D=1.2L) was the same as mentioned before. The optimal size criterion 
for the rings was determined by the two-tailed t-test. 
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Then, In order to check the reliability of the optimal size 
criterion, a population proportion was estimated by the sample proportion 
which was obtained from the results of the two in vivo tests for a large 
number of animals. Two retention tests were done using a different group 




Fabrication of Hydrogel Ocular Insert 
The hydrogel coating thickness for a device was in the range of 0.12 
- 0.13 mm. The average tube diameter of a completed ring device was 1.6 
mm (outside diameter). Typically, 10 to 12 coatings were used for a ring 
device. 
In vivo Drug Release Test of Ocular Inserts 
The release rate of drug samples in the Ringer's preconditioning 
solution was in the range of 485 - 1016 jug/hr. This was similar to the 
results of in vitro tests (Ryoo, 1986). 
Also, the release rate of tylosin tartrate was measured using tear 
samples. The drug concentration of tear samples was measured by using a 
multiple spotting technique in order to increase the developed intensity 
for a spot on a TCL plate. Table 6 represents drug release rates with 
time after ring insertion (healthy cows). 
A minimum inhibitory concentration of 0.63 fxg of tylosin tartrate 
per ml of tear solution (Leytem, 1984), was used to estimate the required 
minimum drug release rate. Assuming a tearing rate of 2 to 4 ml/he, the 
required minimum drug release rate range was calculated to be 1.2 to 2.4 
pg/hr (Ryoo, 1986). Therefore, all of the rate data in Table 6 are seen 
to be above the minimum drug release rate necessary to suppress IBK in 
these cattle. The release rates were found to be in the range of 7 - 160 
pg/hr. According to the above results, there was a large variation in 
drug release rates, as the tearing rate was variable in these in vivo 
tests. However, one ring (VI-46-03) exhibited a nearly constant drug 
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TABLE 6. Drug release rate with time for in vivo testing 
Ring No. Time (days) 
1 2 3 4 5 6  7 8  
VI-42-15 160.6* 25.8 37.9 nt* 
VI-44-02 14.9b nt 
VI-45-01 19.4b 54.6 41.1 nt 
VI-43-02 10.5 15.1 14.7 28.0 nt 
VI-44-01 7.9b 7.1 nt 
VI-46-03C - - 23.0 11.8 22.2 20.6 30.0 nt 
R^elease rate in pg/hr. 
T^hese samples might be mixed with the large amount of tears. 
Q 
This ring was inserted in the same eye after VI-44-01 fell out. 
it 
nt : Ring devices fell out, so further data could not be tested. 
release rate for 5 days. Foreign materials (solids, mucus, etc.) from an 
eye resulted in a long spot trace on a developed TCL plate. This 
elongation of tracings was enough to affect quantitation results, and 
thus the drug release rate values in Table 6 are taken as minimum values. 
Antibiotic Susceptibility of bovis 
The result of bacterial susceptibility tests to antibiotics is shown 
in Table 7. Three antibiotics were checked by comparing the diameter of 
zone of growth inhibition of ^  bovis on a BAP plate.  ^bovis showed a 
sensitive reaction to tylosin tartrate and ampicillin. Therefore, 
tylosin tartrate was selected to suppress the bacterium, ^  bovis, in the 
in vivo experiments. 
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TABLE 7. Susceptibility and zone of growth inhibition 
Name of antibiotic Reaction Diameter of zone 
of growth inhibition 
Tylosin tartrate sensitive 4 mm 
Ampicillin sensitive 5 mm 
Streptomycin resistant 0 mm 
In vivo Experiment for the Treatment of IBK using Ocular Inserts 
Preliminary bacteriological examination 
Bacteriological examination was done to check whether or not 
gram-negative bacteria were in a calf's eyes prior to beginning an in 
vivo infection experiment. If gram-negative bacteria were found in an 
eye, the animal was treated with an antibiotic. Table 8 shows the 
results of preliminary bacteriological examination of each animal group. 





Examination results Treatment 
I 4 Gram-negative bacteria 
were present 
yes 




III 6 one eye showed that 
some bacteria were present, 
but not serious 
no 
IV 4 good condition no 
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Group I aad group II had different types of gram-negative bacteria 
such as M. ovis. In order to make the eyes bacteria-free, an antibiotic 
ointmentl* was applied. Eyes in groups III and IV had few bacteria, and 
therefore were not treated with antibiotics. 
Titration of challenge inoculum of M. bovis 
The concentration and applied dose of ^  bovis challenge inoculum used 
after UV irradiation preconditioning of the eyes for each experiment 
group is shown in Table 9. 
TABLE 9. Concentration and dose of M. bovis challenge inoculum for each 
group 






I 2 0.5 plate/eye^  
II 3 0.5 plate/eye 
III 3 0.5 plate/eye 
IV 2 0.5 plate/eye 
5 ml/eye n.d 
1 ml/eye 1.61 x 10® CFU/ml 
1.33 ml/eye 9.1 x lO^  CFU/ml 
1 ml/eye 2.4 x 10® CFU/ml 
a. 
Here, a plate means a blood agar plate surface that was covered 
with cultured M. bovis colonies 24 hour after inoculation. 
0^.5 plate means half of a BAP surface containing M. bovis 
not determined 
lA (§) 
Ophthocort : composed of chloramphenicol, polymyxin B, sulfate, 
and hydrocortisone, acetate ophthalmic ointment, USP. 
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Rétention data for ocular Inserts 
In group I, a preliminary ring retention test (using a plain PVC 
tube) was performed a week before Instillation of challenge Inoculum In 
order to be reasonably certain of a proper size for a medicated ring to 
be subsequently be used In the experiment (Table 10). 
TABLE 10. Retention time for ring devices for each animal In group I 
I: Insertion; F: fell out; R: removed 
Animal Eye Size (mm) Retention time (days) 
No. eye rlng^  0123456789 10 
149 R 39.5 45.25 I R 
L 39.5 44.25 I—F 
47.25 I R 
150 L 36.5 45.75 I R 
3 
The ring size means the outside diameter of the ring. 
At day 7 after Insertion, all rings were removed and observed to see 
If there was any bulld-up of material on a ring. The rings were found to 
be free of foreign material and the sizing criterion appeared to be 
adequate. The shape seen for all rings after removal Is shown In Figure 
2. 
Ocular inserts (medicated and non-medicated) were inserted into eyes 
and then the eyelids were sutured (groups I, II, and III). However, the 
eyelids were not sutured after insertion of the rings in the case of the 
group IV animals. An example of a ring in place after 7 days following 
insertion is shown in Figure 3. 
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FIGURE 2. Typical shape of a ring device after removal from an eye. 
The ring size (side to side measurement) Is about 50 mm 
FIGURE 3 Eye with ring inserted. A portion of the ring can be seen on 
the right side (cow 8031; 7 days after insertion) 
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The results for the reteatloa characteristics of the rlag devices 
are listed la Table 11. Each case represeats the chaage of reteatloa 
coaditloas from lasertloa to removal. 
TABLE 11. Reteatloa characteristics of ocular iaserts 
Group Aalmal Size (mm) Reteatloa time (days) 
ao. ao. eye® rlag 0123456789 
149L 39.5 46.64 IS^ —P————————————R 
I R 39.5 47.25 IS R 
150L 36.5 45.78 IS-P R 
R 36.5 45.25 IS-0 R 
152L 35.0 44.8 IS R 
R 35.0 45.0 IS—F/IS—0————R 
153L 36.0 45.5 IS-O/S—0 R 
II R 36.0 45.4 IS-O/S——————R 
154L 36.0 45.5 IS—0/—R 
R 36.0 45.4 IS---—-------------—-R 
8002L 37.0 44.1 IS-0 R 
R 37.0 44.6 IS-0 R 
8007L 34.0 41.7 IS 0 R 
III R 34.0 42.1 IS———————P———————————R 
8013L 33.0 41.6 IS-0 R 
R 33.0 37.4 IS———————P———————————R 
8031L 31.0 38.4 IN F 
IV R 31.0 37.8 IN R 
8032L 32.0 39.1 IN R 
R 32.0 38.5 IN—————————————R 
E^ye size was determiaed by measurlag the distaace from the 
medial caathus to the lateral caathus. 
R^lag size is measured as the outside diameter. 
c 
IS: lasert rlag, suture eye; IN: iasert rlag without suturlag 
eye; R: remove rlag aad the sutures; P: partly opeaed eyelid; 0: fully 
opeaed eyelid; F: fell out; S: resuture. 
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Among the groups (I, II and III) In which suturing was performed, 13 
of 16 eyelids opened within 3 days after suturing. In general, the 
sutures did not last for 7 days. Most of inserts (15 out of 16 rings) 
for animals receiving sutures were retained until the end of the 
experiment. The results for the non-suture group (IV) also showed good 
retention characteristics for the ring devices (one for 6 days and three 
for more than 7 days). This demonstrated the potential to use ring 
devices in field applications without suturing eyelids. Signs of 
undesirable side effects or eye irritation were not found (except a minor 
increase in tearing at the initial time of ring insertion). 
Quantitative results of M. bovis colonization in the eyes 
None of the calves were infected or developed IBK before receiving 
the challenge exposure. The effectiveness of hydrogel ocular inserts for 
the treatment of IBK was evaluated by comparing the number of ^  bovis 
colony forming units with the number found for the control eye in tear 
swab samples collected at 2-day intervals throughout the test period. 
All ten calves (19 of 20 eyes) were infected with M. bovis after using 
the UV radiation eye preconditioning method. These data are shown in 
Table 12. 
Figures 4 - 13 represent plots of the logarithm of the number of 
colony forming units per tear swab sample as a function of time for the 
14 days experiments. Each figure can be examined for changes within two 
time periods. The first 7-day period shows the trend in the generation 
and build-up (in most cases) of bacteria in the eye after inoculation 
with bovis. The second 7-day period indicates the general pattern of 
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TABLE 12. Number of colony forming units as an index of changes of 
M. bovis content in the eye 
(Data expressed as log^ qCFU/swab) 
Group Animal* Days after inoculation with M. bovis 
No. No. and after inoculation after treatment^  
eye 0 3 5 7 l(2)b 3(4) 5(6) 7(8) 8(10) 
I 149L 0 4.87 4.40 3.86 0 0 1.38 1.32 0 
R 0 4.83 5.13 2.73 3.10 0.78 5.33 3.83 3.20 
150L 0 4.17 4.15 3.37 0 0 0 0 0 
R 0 0.47 4.15 3.93 3.47 3.03 0.47 0 3.20 
II 152R 0 4.95 4.32 3.57 0 0 0 0 0 
L 0 3.47 3.88 4.59 5.34 5.76 5.39 2.65 0 
153R 0 4.08 5.56 4.11 0 0 0 0 0 
L 0 5.08 5.95 4.14 4.35 6.00 4.95 5.21 0 
154L 0 5.19 4.03 4.41 0 0 0 0 0 
R 0 4.38 2.96 4.50 4.73 5.03 5.89 6.08 0 
III 8002R 0 4.32 4.30 3.93 0 0 0 0 0 
L* 0 0 0 0 0 0 0 0 0 
8007L 0 2.60 3.82 2.55 0 0 0 0 0 
R 0 3.07 2.80 4.69 4.17 5.85 6.13 5.73 0 
8013L 0 2.11 2.65 2.08 0 0 0 0 0 
R 0 4.26 3.18 2.73 5.05 5.93 4.35 5.01 0 
IV 8031R 0 2.99 3.23 4.86 1.38 0 0 0 0 
L 0 3.60 3.89 4.50 5.73 4.50 3.85 3.95 1.43 
8032R 0 2.99 4.26 4.69 0 0 0 0 0 
L 0 1.95 2.26 4.50 3.65 0 2.80 0 0 
Both eyes of each calf were used (one as control eye and one as 
treated eye). First row for each calf eye number represents the data of 
a treated eye, while second row represents those of a control eye. 
L = left eye, R = right eye. 
D^ata within parenthesis in this row are applied only to group I. 
Days after treatment means the period after insertion of ring 
devices. 
O^ne eye (8002L) in group III did not show any H. bovis. 
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the change of the number of bacteria as a function of time after 
inserting the ring devices. Two types of ring devices were used, a 
medicated and a non-medicated ring type. The control eye received a 
non-medicated ring, and the other eye received a medicated ring and 
therfore becomes the treated eye. Both rings were inserted at day 7 and 
were removed at day 14. At day 14, the infected control eyes were 
treated using a fresh medicated ring (for groups II and III) or an 
Azimycin®subconjunctival injection (for group IV) in order to treat the 
M. bovis infection. 
In the first 7-day period, the bacteria increased in number rapidly 
within 3 days in both eyes. Then, the growth rate appeared to stabilize 
(10^  - 10^  CFU/swab), exhibiting only minor fluctuations. However, the 
bacterial growth trend for both eyes during the second 7-day period was 
different from that seen during the first period. That is, the number of 
M. bovis colonies of the treated eyes dropped dramatically within one or 
two days after the medicated rings were inserted, while the number of 
M. bovis colonies that developed from the swab sample of the control eye 
maintained levels similar to that seen during the first 7-day period. 
After day 14, all treated eyes and the poat-treated control eyes showed 
the presence of no, or only a few (negligible numbers), bacterial 
colonies. The number of colony forming units associated with the swab 
tear samples provides a useful index to monitor changes taking place in 
the eyes in the number of ^  bovis bacteria present for the time period 
covering the initial inoculation with ^  bovis to the end of the 
experiment (day 17) when a swab sample was taken 2 days after removal of 
the medicated rings from the control eyes. The effect on the numbers 
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during this period include those associated with the insertion of rings 
(if any), the removal of rings, and the insertion of a medicated ring 
Into control iyes. 
3 5 7 9 11 13 15 17 
Days after inoculation with M. btyuia 
149L 149R 
FIGURE 4. The bacterial growth trend with time for calf 149 
Figure 4 shows the bacterial growth trend with time for calf 149. 
Here, two data points for the treated eye (days 13 and 15 of 149L) show 
tens of colonies even after the treatment using a medicated ocular 
Insert; however, this amount is much less than that of the control eye 
(in the range of tens of thousands). One datum from the control eye (day 
11 of 149R) represents a relatively low number of bacteria compared with 
the other data for control eye (149R). This eyelid was sutured during 
all of the experimental time period. Therefore, the discrepancy may come 
from a false sampling (due to the eyelid being sutured shut). If a swab 
sample Is not obtained from deep in the conjunctival sac, the sample may 
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not be representative. However, a general trend is present. In the case 
of the treated eye, the bacterial growth was controlled by the medicated 
ring, while the control eye had a large number of bacteria present 












Days after inoculation with M. hovis 
150L -B- 150R 
FIGURE 5. The bacterial growth trend with time for calf 150 
Figure 5 shows the bacterial growth trend with time for calf 150. 
Two data points for the control eye (days 13 and 15 of 150R) indicate a 
low number of bacteria being present compared with other data for the 
control eye. Then, the bacterial growth seen for day 17 appears to 
increase back to the relatively high level seen prior to insertion of the 
control ring. These two low data points may also be explained by the 
difficulty of sampling for an eye that has the eyelids sutured tightly. 
By comparison, the treated eye was apparently cleared of M. bovis (no 
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colonies in the eye after inserting a medicated ring) for the 7 days 
following ring Insertion. 
Ô 
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Days after inoculation with M. hovis 
— 152L 152R 
FIGURE 6. The bacterial growth trend with time for calf 152 
Figure 6 shows the bacterial growth trend with time for calf 152. 
The results show a consistent trend for bacterial growth for both eyes. 
After ring insertion, the two curves representing bacterial growth in the 
control and in the treated eye are quite different. The treated eye 
(152R) has no M. bovis detectable for 7 days, while the number of 
bacteria in control eye (152L) remains very large for this same period in 
the experiment. In case of 152R, the medicated ring fell out one day 
after insertion, but the effect of drug was to eliminate the M. bovis 
within 1 day and subsequently, for the remainder of the experiment, the 
Infection did not become reestablished. 
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0 2 4 6 8 10 12 14 16 
Days after inoculation with Af. bovis 
153L -B- 153R 
. IGURE 7. The bacterial growth trend with time for calf 153 
Figure 7 shows the bacterial growth trend with time for calf 153. 
The trend of bacterial growth was similar to that seen for the calf data 
of Figure 6. This figure shows a significant difference between the 
control eye and treated eye for the time period following insertion of 
the rings. All of the data for the control eye and for the first 7-day 
period data of the treated eye show a large number of colony forming 
units present (over 10^  CFU/swab). In the first 7-day time period, both 
curves (for the treated eye and for the control eye) have a similar shape 
for the representation of numbers of bacteria with time. 
Figure 8 shows the bacterial growth trend with time for calf 154. 
These curves have similar trends for treated and control eyes as seen for 
data of Figures 6 and 7. 
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2 4 6 B 10 12 14 
Days after inoculation with M, bovis 
IGURE 8. 
154L -0- 154R 
The bacterial growth trend with time for calf 154 
2 4 6 6 10 12 14 
Days after inoculation with M. hovis 
FIGURE 9. 
8008L —8003R 
The bacteria growth trend with time for calf 8002 
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Figure 9 shows the bacterial growth trend with time for calf 8002. 
Note, however, that the left eye (8002L) did not yield any M. bovls 
colonies during the entire experiment period. The right eye (treated 
eye) did respond during the first 7-day period, and after a medicated 









0 2 4 6 8 10 12 14 16 
Days after inoculation with M, hovis 
8007L -B- 8007R 
rIGURE 10. The bacterial growth trend with time for calf 8007 
Figure 10 shows the bacterial growth trend with time for calf 8007. 
The general pattern of the control and treated eye curves is similar to 
those seen Figures 6 to 8. However, the number of bacteria in the 
control eye gradually continued to increase up to day 12 (to 10^  
CFU/swab), and then decreased slightly at day 14. When a medicated ring 
was inserted into the control eye on day 14, the bacteria were no longer 
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Days after inoculation with M, bovis 
0O13L 8013R 
FIGURE 11. The bacterial growth trend with time for calf 8013 
Figure 11 shows the bacterial growth trend with time for calf 8013. 
The general trend of bacterial growth seen for the control and for the 
treated eye is similar to that seen in many of the Figures (e.g., Figures 
6 to 8). 
Figure 12 shows the bacterial growth trend with time for calf 8031. 
Eyelids of this calf were not sutured following ring Insertion. The 
trend of bacterial growth for control and treated eyes is similar to 
Figure 7, although at day 8 a few (negligible) M. bovis colonies were 
detected in the swab sample from the treated eye (8031R). Also, note 
that the number of control eye bacteria apparently decreased with time 
after day 8. 
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Days after inoculation with M. hovis 
/IGURE 12. 
—- 8031L 8031R 
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Days after inoculation with Af. hovis 
8032L -e- 8032R 
rIGURE 13. The bacterial growth trend with time for calf 8032 
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Figure 13 shows the bacterial growth trend with time for calf 8032. 
Two data points for swab samples from the control eye (days 10 and 14) 
were zero. Ten milliliters of tetracycline^  ^were injected 
intramuscularly at day 8 to cure a severe cough that this calf had. The 
effect of this injection can continue for 48 - 72 hours after the time of 
injection (R. F. Rosenbusch, personal communication)and this may 
explain the control eye observations at day 10. However, it is also 
possible there was a sampling problem at that time. Also, note that at 
day 12 the number of colony forming units was relatively high again. 
Nevertheless, the medicated ring data were constant at zero colony 
forming units throughout the second 7-day period. 
Clinical examination 
All eyes were observed to assess their condition during the progress 
of an infection. The results for each animal group are represented in 
Tables 13 - 16. 
^^ LA-200, Pfizer, Terre Haute, IN. 
Veterinary Medical Research Institute, Iowa State University, 
Ames, lA. 
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TABLE 13. Dally clinical observations for group I 
Days Procedures Clinical observation* 
-1 1st UV radiation 
0 2nd UV radiation; 
the challenge exposure 
with M. bovls 
3 Sample 2 calves Purulent exudate in the eye 
5 Lacrlmination for all eyes 
7 Sample 2 calves 
ring in; suture 
Same as day 5 
9 Sample 2 calves Conjunctivitis for 149L, 150L and 150R 
10 Read results Same as day 9 
13 Sample 2 calves Small corneal opacity on 150R eye; 
Other eyes were same as day 10 
15 Remove suture; 
sample 2 calves 
Corneal opacity (5 mm dla.) on ISOR; 
No significant signs of IBK on 149 
C^ontrol eyes: 149R and 150R; treated eyes: 149L and 150L. 
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TABLE 14. Dally clinical observations for group 11 








Ist UV Irradiation 
2nd UV Irradiation; 
the challenge 
exposure with ^  bovls 
Sample 3 calves 
Sample 3 calves 
Ring in; suture 
Sample 3 calves 
Sample 3 calves 
Sample 3 calves 
Suture out; remove 
ring;sample 
3 calves 
153L and 154R eyes looked like a more 
serious infection (more swelling and 
tearing) compared with the other eyes of 
the calves 
153L: corneal opacity (7 mm) 
154L: corneal opacity (20 mm), and 
center of opaci ^  was pulled 
out (5 mm) 
154R: lacrimination and swelling 
Same as day 5 
Don't know (eyelids were sutured) 
Same as day 8 
Same as day 8 
152L, 152R, 133R and 154R: normal 
153L: cloudy lesion (10 mm) 
154L: lesion was healed (white and 
smooth; not yellowish in color) 
154L. 
Control eyes: 152L, 153L and 154R; treated eyes: 152R, 153R and 
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TABLE 15. Dally clinical observations for group III 









1st UV Irradiation 
2nd UV Irradiation; 
challenge exposure 
with ^  bovls 
Sample 3 calves 
Sample 3 calves 
the 
Read the results 
Sample 3 calves 
ring In; 
suture 
Sample 3 calves 
Sample 3 calves 
Sample 3 calves 
Remove suture 
8007L: corneal opacity (3 mm) 
8013L: corneal opacity (6 mm) 
8002L, 8007R, 8013R: no major signs 
8002R: animal tried to close eye 
(light sensitive) 
8007L: corneal lesion (2 mm) 
8013L: corneal lesion (5 mm) 
8002L, 8007R, 8013R: normal 
8002R: 3 mm of corneal opacity 
8007L and 8013L: same as day 5 
8002L, 8007R and 8013R: normal 
8002R: white cornea changed to 
a gray color, but 
center part (5-7 mm) was white 
8007L: corneal lesion (2 mm) 
8013L: corneal lesion (5-7 mm) 
8007L: tearing 
8002L; 8007R, 8013R : normal 
8002R: some opacity 
8007L, 8013L: like normal 
8002L» 8007R, 8013R: normal 
8002R: lesion was healed (center part of 
eye was normal and some 
vascularization evident) 
Control eyes: 8002L, 8007R and 8013R; treated eyes: 8002R, 8007L and 
8013L. 
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TABLE 16. Dally clinical observations for group IV 
Days Procedures Clinical observation* 
-1 
0 
1st UV irradiation 
2nd UV Irradiation; the 
challenge exposure 
with M. bovis 
Sample 2 calves 
Sample 2 calves 
Ring in; 
No suture 
8 Read the results 
Read the results 
11 Read the results 
12 Sample 2 calves 
14 Remove ring; treat 
Infected eye with 
Azlmycln® 
8031R: 3 mm and 7 mm corneal opacity 
8032R: 6 mm corneal opaclQr; entire 
cornea changed to a gray color 
8031L, 8032L: normal 
8031R: same as day 3 
8032R: more serious than day 3; 
scar occured in the center of 
the cornea 
8031L; 8032L: normal 
8031R: tearing; opaque cornea; white 
circle (7 mm) in center of cornea 
8032R: more tearing, focal white 
spot (10 mm); marked 
conj une tivitis 
8032: serious coughing (treat with 
tetracycline injection (10 ml)) 
8032R: had vascularization in cornea 
8031R and 8032R: improved 
8031L; 8032L: normal 
8031R: more tearing, still small opaque 
spot (5 mm) 
8032R: less tearing, improved; 
color change from white to brown 
8031R, 8032R: improved; clearer cornea 
than before 
8031R: vascularization surrounding 
corneal opacity 
8031L, 8032L: normal 
803IR, 8032R: healing process in 
progress 
Control eyes: 8031L and 8032L; treated eyes: 8031R and 8032R. 
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After the inoculatloa using ^  bovis, clinical signs for the 
infected eyes changed from the normal state to either stage 1 or stage 2 
(Hughes, 1981). The change of clinical observations with time is listed 
in Table 17. Some eyes (8 out of 20) did not show clinical signs of IBK, 
even though ^  bovis colonies were found in swab samples taken from the 
infected eyes (19 out of 20). Seven out of 20 eyes showed mild to more 
severe signs of infection. Most of the eyes showing the more severe 
signs were used as treated eyes (i.e., they received a medicated ring) in 
order to see if the use of medicated ring devices had any positive 
correlation with improvement in clinical signs for infected eyes. 
After applying ring devices, the mild or more severe clinical signs 
of the medicated eyes changed to the normal sign or healing process sign 
(after Jackson, 1953). For the eyes receiving medicated rings, two of 
the 10 eyes exhibited no signs of IBK throughout the treatment period. 
Eight of the 10 eyes showed improvement. Of these 8 that showed 
improvement, 4 changed back to what appeared to be a normal condition 
(i.e., no signs of IBK). However, the clinical signs for 2 out of 10 
non-medicated eyes continued to gradually worsen with time. These data 
are summarized in Table 18. 
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TABLE 17. The change of clinical observations with time* 
Group Animal Days after inoculation with M. bovis Ring 
No. eye no. 0 3 5 7 8(9) 10(11) 12TÎ31 14(15) type*» 
I 149L 0 0 1 1 2 2 2 0 M 
149R 0 0 1 1 dk dk dk 0 NO 
150L 0 0 1 1 2 2 2 0 M 
150R 0 0 1 1 2 2 3 3 NO 
II 1S2L 0 0 0 0 dk dk dk 0 NO 
152R 0 0 0 0 dk dk dk 0 M 
153L 0 1 3 3 dk dk dk 4 NO 
153R 0 0 0 0 dk dk dk 0 M 
154L 0 1 4 4 dk dk dk H M 
154R 0 0 1 1 dk dk dk 0 NO 
III 8002L 0 0 0 0 0 0 0 0 NO 
8002R 0 0 1 3 3 2 2 H M 
8007L 0 3 4 4 1 0 0 0 M 
8007R 0 0 0 0 dk dk 0 0 NO 
8013L 0 3 4 4 dk 0 0 0 M 
8013R 0 0 0 0 4k dk 0 0 NO 
IV 8031L 0 0 0 0 0 0 0 0 NO 
8031R 0 3 3 4 3 H H H M 
8032L 0 0 0 0 0 0 0 0 NO 
8032R 0 3 4 4 3 H H H M 
*The number in the column represents clinical observations: 
0 - no significant sign, 1 - initial sign (photophobia, epiphora and 
blepharospasm; Punch and Slatter, 1984), 2 - conjunctivitis, 
3 - keratitis, 4 - central cornea ulceration, 5 - perforation of 
corneal ulceration, corneal scar and blindness, H - healing process, 
and dk - don't know due to eyelids being sutured shut. Signs 2 and 3 
are relatively mild, 4 is more severe and 5 is severe (after Jackson, 
1953). 
R^ing type is divided into two types: M - medicated, and 
NO - non-medicated. 
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TABLE 18. Clinical signs: medicated and non-medicated devices 
Before ring insertion After ring insertion 
Clinical signs No. of Applied Clinical signs* No. of 
day 0 day 7 cases ring type day 7 day 14 cases 
normal to normal 8 non-medicated normal to normal 6 
medicated normal to normal 2 
normal to Initial 5 non-medicated initial to mild 1 
non-medicated initial to normal 2 
medicated initial to normal 2 
normal to mild 2 non-medicated mild to more 
severe 1 
medicated mild to healing 1 
normal to more 5 medicated more to normal 2 
severe severe healing 3 
Total 20 Total 20 
This is defined as the follows: normal sign - no change on 
the eye; initial - photophobia, epiphora, and blepharospasm; mild -
conjunctivitis or keratitis; more severe - central corneal ulceration; 
healing - vascularization of cornea (after Jackson, 1953; Punch and 
Slatter, 1984). 
The initial dose of ^  bovis challenge inoculum (Table 9) shows no 
correlation with the degree of development of signs of IBK (Tables 17 and 
18; comparisons among control eyes within groups at day 7 and day 14). 
Drug release from medicated ocular inserts 
Drug release rates from an ocular insert in an eye were difficult to 
measure for the cases where the eyelids were sutured. Thus, the total 
drug release amount for a ring device was estimated by subtracting the 
weight of a ring after removal from the original weight of a ring. Table 
19 shows the total drug release amounts from medicated ocular inserts of 
each group. These values are compared with the initial drug loading. 
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TABLE 19. Summary of total drug release amounts 
Group » Eye Ring Ring weight(g) Total Initial Release 
No. No. No. before after release drug ratio 
Insert insert amount loading 
I 149L* 45-4 » « « « 
150L 44-5 0.2711 0.2511 20 mg 53 mg 37.7% 
II 152R® 44-11 « « « 
153R 43-17 0.3813 0.2334 24.6 mg 47.4 mg 51.8% 
154L 44-15 0.4512 0.2492 33.0 mg 55.2 mg 59.8% 
III 8002R 43-18 0.2539 0.2229 31 mg 44.6 mg 69.5% 
8007L 43-07 0.2526 0.2213 31.3 mg 48.5 mg 64.5% 
8013L 43-08 0.2443 0.2130 31.3 mg 46.2 mg 67.7% 
IV 8013R 40-9 0.2397 0.2204 19.3 mg 47.4 mg 40.7% 
8032R 40-27 0.2392 0.2231 16.1 mg 45.7 mg 35.2% 
R^ing device fell out before removal. 
The total drug amounts released from the ring devices having an 
initial total drug loading of approximately 50 mg were in the range of 16 
- 33 mg. The values in group I and group IV were similar to those of the 
in vitro experiments. However, the total amounts of drug released in 
group II and group III were larger than those seen in vitro experiments. 
This is an interesting result that can be compared with the quantitative 
analysis of ^  bovis. The rings used in groups (II and III) that 
released the relatively larger amounts of tylosin tartrate (compared with 
groups I and IV) exhibit the best IBK treatment results as shown in the 
consistent results of the Immediate decrease of ^  bovis colony forming 
units for eyes receiving medicated rings (the data listings of Table 12). 
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Post"treatment for Infected control eyes 
After removing the non-medicated ring devices from the control eyes, 
new medicated ring devices were used to treat the bacterial Infections of 
the control eyes. Also, Intramuscular Injections containing 
oxytetracycline were used Immediately as an additional treatment to 
reduce ^  bovls bacterial numbers to nondetectable levels. In group IV, 
one of the present field treatments, Azimycln®lnjectlon on 3 to 5 spots 
of the subconjunctival area, was used to provide a comparison of a field 
treatment method with that of the treatment method using medicated ocular 
inserts. These results are summarized in Table 20. 
TABLE 20. Summary of post-treatment for Infected eyes used as controls 
(Unit; logjQ CFU/swab) 
Group Animal eye Treatment M. bovls colony amount 
No. No. "Before after 
la 149R oxyte tracycline 3.2 n.d 
150R intramuscular 3.2 n.d 
injection 
II 152L apply medicated ring. 2.65 0 
153L then oxytetracycline 5.21 0 
154R Intramuscular 6.08 0 
Injection 
III 8002L same as group II 0 0 
8007R 5.73 0 
8013R 5.01 0 
IV 8031L Azlmycln®(0.7 ml) on 3.95 1.43 
8032L subconjunctlva area 0 0 
I^n this group, medicated ocular Inserts were not used after 
removal of non-medicated rings. 
not determined. 
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The treatment using medicated ocular Inserts Is very effective in 
treating IBK within a short time. The current field treatment (applied 
to group IV animals) also showed good results. 
In vivo Experiment for the Retention of Ring Devices 
Preliminary retention tests 
Table 21 shows the results of the preliminary retention test (see 
also preliminary retention test section of methods and materials) for 
establishing a formula to select ring sizes with a specific level of 
confidence. 
Twen^  eight ring devices were used. The eye size range was 36.5 -
47 mm. Some of ring devices were medicated hydrogel ring devices, 
because they were also used for detecting the amount of drug released. 
Only two calves (149 and 150) received plain polyvinyl chloride tube 
inserts. The size was determined in relation to the eye size of the 
experimental animals. The size of the ring devices was selected to be 
either similar to or bigger than the eye size. The retention formula was 
determined by relating the measured eye size and the applied ring size to 
the number of days that the particular ring was retained in an eye. 
84 
TABLE 21. Preliminary retention test data for selecting ring size 
Animal Eye Ring Data Retention 
No. size (mm) No. Material* Size (mm) time 
325 45.0 42-4 VI 42.0 1 day 
42-5 VI 42.0 1 day 
42-7 VI 42.5 1 day 
42-20 VI 42.5 1 day 
329 44.0 42-6 VI 42.0 8 hr 
42-15 VI 43.0 1 day 
215 46.0 44-1 VI 45.8 2 days 
44-2 VI 45.2 2 days 
45-1 VI 45.3 4 days 
45-3 VI 44.6 3 days 
46-1 VI 45.7 1 day 
46-3 VI 46.2 6 days 
310 47.0 43-3 VI 44.0 1 day 
44-3 VI 45.1 1 day 
311 44.0 43-2 VI 43.5 5 days 
45-2 VI 45.8 1 day 
46-2 VI 44.3 1 day 
345 (39.5)® 42-13 VI 40.4 1 day 
42-18 VI 43.5 8 days 
352 (37.0)® 42-17 VI 40.3 5 days 
42-19 VI 39.8 1 day 
750 39.5 43-4 VI 44.04 >6 days 
43-5 VI 45.04 >6 days 
757 37.5 43-6 VI 44.76 >6 days 
44-6 VI 44.84 >6 days 
149 39.5 — PVC 47.25 >7 days 
- PVC 45.25 >7 days 
150 36.5 — PVC 45.75 >7 days 
Ring material Is divided Into two types: VI - hydrogel-coated 
ring device containing SO mg of tylosin tartrate and PVC - ring device 
of plain polyvinyl chloride tubing (0.044" I.D. x 0.065" O.D.). 
R^lng size Is outside diameter. 
Q 
Measurement made after ring was Inserted. 
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Figure 14 shows a plot of the difference between the selected ring 
size and the measured eye size versus the retention time. This figure 
was based on data listed In Table 21. 
-2 0 2 4 6 8 
Ring size minus eye size (mm) 
FIGURE 14. Retention time as a function of the ring size and the eye 
size difference 
Figure 14 shows that the rings having a diameter that is 4 to 10 mm 
larger than the eye size were retained In the eyes for more than 6 days. 
As this represented the best retention characteristics, an initial or 
preliminary size criterion was that the ring should be 4 to 10 mm larger 
than the eye size (side-to-side measurement). Table 22 shows the results 
of the retention test using this preliminary criterion. 
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TABLE 22. Retention data using the preliminary size criterion 
Animal Eye Ring Data Retention Remarks 
No. size (mm) No. Material* Size (mm) time 
149 39.5 45-4 VI 46.64 >3 days suture 
- PVC 44.25 1 day 
PL-2 PVC 47.25 2 days 
150 36.5 44-5 VI 45.78 >3 days 
PL-1 PVC 45.25 9 days 
152 35.0 42-28 VI 41.2 >3 days suture . 
43-11 PI 44.8 >1 day 
44-11 VI 45.0 1 day 
43-1 PI 42.5 >2 days 
153 36.0 43-9 VI 43.1 1 day 
49-11 PI 45.5 >5 days II 
43-17 VI 45.4 >1 day II 
154 36.0 44-15 VI 45.5 >1 day II 
44-9 PI 45.4 suture out M 
44-8 VI 43.0 >3 days 
8002 37.0 44-12 VI 44.6 >1 day suture 
43-10 PI 44.1 >6 days 
43-18 VI 44.6 >6 days 
8007 34.0 43-7 VI 41.7 >5 days II 
43-2 PI 44.1 suture out 
41-28 VI 41.1 >1 day II 
8013 33.0 43-8 VI 41.6 >6 days II 
40-3 PI 37.4 suture out It 
41-29 VI 40.6 >1 day 
8031 31.0 40-2 PI 38.4 6 days 
40-9 VI 37.8 >7 days 
8032 32.0 47-7 PI 39.1 >7 days 
40-27 VI 38.5 >7 days 
Ring material is divided Into two types: VI - bydrogel-coated 
ring device containing 50 mg of tylosin tartrate, PVC - ring device of 
plain polyvinyl chloride tubing (0.044" I.D. x 0.065" O.D.), and 
PI - hydrogel-coated ring device without drug. 
R^ing size is outside diameter. 
Retentjpg tests using the optimal crlterlon for ring size 
Even though the retention data In Table 22 were better than that of 
Table 21, they were not consistent enough. Therefore, the data of 
seventeen rings (having at least 4.5 mm bigger size than the eye size) 
that were retained for more than 5 days were selected from Tables 21 and 
22 In order to design an Improved criterion for selecting ring size. 
Also, the structure of a cow's eye was considered In developing an 
Improved empirical relationship between the measured eye size and the 
desired ring size for Insertion. First, the optimal size of a ring, D, 
was assumed to be 1.2 times the measured side to side eye size, L. Then, 
the acceptable range of ring sizes was calculated by using the following 
two tailed t-test (Cox, 1987). 
All of the 17 ring sizes selected from Tables 21 and 22 were divided 
by their associated eye size measurement. For example, the x value for 
the right eye of calf 8031 (refer to Table 22, 8031R) is 37.8/31.0 = 
1.2194. For the number of random samples, n, there are seventeen 
individual values, or n = 17. An hypothesis, D = 1.2L, is tested as to 
whether or not the true value for the average value of the x-value ratios 
of the ring size and eye size data, p, is p = 1.2. In this development, 
a is taken as the probability of making a Type I error. A Type I error 
occurs when the true test hypothesis is rejected. The analysis proceeds 
as follows: 
Step 1. 
jyi=1.2 — The true hypothesis is that jut = the average 
of the X values 
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/yi^ l.2 The alternative hypothesis is the rejection 
of the hypothesis that p=1.2 
a=0.05 —— The probability of making a Type I error; 
the hypothesis is tested at a probability 
= 0.05 
Step 2. 
x=l.20652 — The average of the 17 ratio values is 1.2; 
sample mean 
Sjç=0.04218 — the standard deviation 
X lO"^  — The variance or square of the 
standard deviation 
S-=,i.o23 X lo"^  — the square root of the variance 
divided by the number of samples 
*2=0.6373 ; test statistic The significance of the 
normally distributed sample mean, or test 
statistic, is defined as 
 ^  ^1.20652 - 1.2 
x^ 1.023 X 10"2 
Step 3. 
Assuming x^  ^  NI(fl=1.2, o^ ) for i = 1 to 17, the 
test statistic is a member of the t-distribution with n-1 
degrees of freedom. Assuming each ratio value, x^ , 
follows a normal distribution curve with the true 
value=1.2 and a variance, a^ , the test statistic is 
a member of the t-distribution with (n-1) degrees of 
freedom where n is the number of samples. 
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Step 4. 
Using the t-Varlate Probabilities Table (Cox, 1987), for 
16 degrees of freedom and 0.025 (= a/2 = 0.05/2; left and 
right side of the probability curve), it is found that 
t(16, 0.05/2)^ 2.120. If the test statistic, t^ , is less 
than 2.120 for 16 degrees of freedom at the probability 
of Interest, the test hypothesis for the probability of 
making a Type I error at 0.05 is accepted. In this case, 
the test statistic value is 0.6373 < 2.120, and so the 
test hypothesis that p=1.2 is accepted for a=> 0.05. 
Step 5. 
The 95% confidence interval about the value for fi is 
IX = 1.20652 ± (2.120)(1.023 x 10"^ )= 1.20652 ± 0.02169 
Thus, 95% of the time for the true value of 1.2, the value 
can be found within the range of 1.18 to 1.23. The error 
in using this range is 5%. 
Therefore, the optimal criterion for selecting a ring size is 
determined to be 1.18L < ring size < 1.23L, where L is the measured 
side-to-side eye size. This criterion was then applied in a large scale 
retention test. The retention test data using the optimal criterion for 
ring size selection are listed in Table 23. This data base was obtained 
using a total of 38 cows. The measured eye size for these cows was in 
the range of 41 - 45 mm. 
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TABLE 23. Retention data using the optimal criterion for selecting a 
ring size 
Animal Eye Ring Data . Retention Remarks 
No. size^  (mm) No. Material Slze^ (mm) time 
203 42.0 51-7 PI 50.5 >7 days 
51-2 PI 50.9 >7 days 
922 42.0 51-6 PI 50.1 >7 days 
51-8 PI 50.0 >7 days 
205 41.0 51-5 PI 49.2 >7 days 
51-9 PI 49.4 >7 days 
232 41.0 51-1 PI 49.4 >7 days 
51-11 PI 49.5 >7 days 
277 41.0 51-10 PI 49.3 >7 days 
539 41.0 51-12 PI 49.3 >7 days 
9559 43.0 55-7 PI 50.5 >7 days 
55-23 PI 50.7 >7 days 
9583 44.0 56-15 PI 53.0 1 day removed 
56-9 PI 53.0 >1 day fell out 
8768 45.0 57-22 PI 54.0 >7 days 
57-2 PI 54.7 <1 day fell out 
9459 43.0 56-21 PI 51.8 >1 day fell out 
8973 45.0 57-8 PI 53.8 >7 days 
56-28 PI 53.8 >7 days 
9433 41.0 (L) 54-2 PI 49.0 3 days removed 
42.0 (R) 56-16 PI 50.1 >7 days 
9598 45.0 56-22 PI 55.1 >1 day fell out 
57-21 PI 55.2 >7 days 
9294 44.0 56-13 PI 53.2 >7 days 
56-14 PI 53.3 >7 days 
9557 46.0 57-1 PI 55.4 >7 days 
56-19 PI 55.5 >7 days 
9606 45.0 56-27 PI 53.5 <1 day fell out 
56-30 PI 53.5 >7 days 
9531 44.0 56-17 PI 52.8 >7 days 
56-10 PI 52.2 >7 days 
R^ing size Is outside diameter. 
P^I: hydrogel-coated ring device without drug. 
T^he optimal criterion for the selection of the ring size 

























Eye Ring Data U  ^ Retention Remarl 
size^  (mm) No. Material Size (mm) time 
42.0 55-16 PI 50.3 >7 days 
55-18 PI 50.9 >7 days 
42.0 55-22 PI 50.9 >7 days 
55-24 PI 50.9 >7 days 
41.5 55-10 PI 50.4 >7 days 
55-12 PI 50.1 >7 days 
44.0 57-14 PI 53.7 >1 day fell out 
56-11 PI 53.5 >1 day fell out 
41.0 56-1 PI 49.1 >1 day fell out 
55-17 PI 49.0 >7 days 
41.0 54-3 PI 49.0 >7 days 
54-4 PI 49.8 >7 days 
40.0 53-4 PI 48.0 >7 days 
53-3 PI 48.3 >1 day fell out 
42.0 (L) 57-20 PI 50.8 >7 days 
43.0 (R) 56-18 PI 51.8 >1 day fell out 
42.0 (L) 56-23 PI 50.3 >7 days 
41.5 (R) 55-19 PI 50.1 >7 days 
43.0 55-14 PI 51.0 >7 days 
55-15 PI 51.3 >7 days 
43.5 56-26 PI 53.9 >7 days 
56-27 PI 53.5 >7 days 
44.0 56-8 PI 52.2 >7 days 
55-8 PI 52.0 >7 days 
46.0 57-17 PI 55.7 1 ttr removed 
57-18 PI 55.9 1 hr removed 
40.5 (L) 53-5 PI 48.4 >7 days 
41.0 (R) 49-3 PI 48.3 >7 days 
42.0 56-7 PI 51.3 >7 days 
56-12 PI 51.4 >7 days 
43.0 (L) 55-9 PI 51.3 >7 days 
42.0 (R) 55-13 PI 50.5 >7 days 
43.0 55-20 PI 51.8 >7 days 
55-11 PI 52.0 >7 days 
43.5 56-24 PI 52.9 >7 days 
40.5 49-1 PI 48.2 >7 days 
40.0 49-5 PI 48.0 >7 days 
49-6 PI 48.1 >7 days 
40.0 51-3 PI 48.0 >7 days 
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The results of the retention tests of Table 23 using the optimal 
criterion for ring size selection are summarized in Table 24, 
TABLE 24. Results of retention tests using the optimal criterion for 
ring size 
Number Number Removal 
animals rings <24hr >24hr 
Rejection Retention for 7 days 
<24hr >24br No. of Ratio(%) 
(Table 23) ring 
6 10 - - - - 10 100 
11 21 1 1 2 3 14 67 
12 24 0 0 0 5 19 79 
9 15 2 0 0 0 13 87 
Total 38 70 3 1 2 8 56 80 
A total of seventy eyes was used in the retention tests (Table 23 or 
24). All of the rings for the beef cattle (row 1 of Table 24) were 
retained for more than 7 days. By comparison, rings for dairy cattle 
(rows 2, 3 and 4 of Table 24) resulted in somewhat different retention 
results. Four of the 70 rings of Table 24 were removed from the eyes 
because of excessive tearing associated with the separation of joints. 
Ten rings fell out of the eyes either immediately or at some time during 
the experiment period. From Table 24, the overall total success rate for 
>7 day retention was about 80%. Table 25 contains a summary of several 
factors which provide a basis for understanding why some rings fell out 
or had to be removed before the end of the 7-day test period. These 
observations (Table 25) are for dairy cattle (Tables 23 or 24). 
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TABLE 25. Conditions foc ring retention experiments 
Row Eye size 
No. Avg.fS.D. 







2 44.09±1.31 weak 0.5 - 1 67 
3 42.17±1.21 strong 3 79 
4 42.0 ±1.89 strong 3 87 
The rings associated with the factors listed in Table 25 were all 
prepared the same way. Rings for each row number of Table 25 were used 
on different days, and those of row 2 were applied first. The joints 
separated in several cases and so for rings used at a later time (refer 
rings of rows 3 and 4 of Table 25), Joints were strengthened, rings 
received an additional hydrogel coating, and a longer preconditioning 
time was used. Note that the retention success rates are higher for the 
rings of rows 3 and 4 compared with that of row 2. 
Estimating a population proportion from retention data 
A statistical analysis of the retention data (Table 24) was 
performed in order to estimate a population proportion (any large group 
of cattle). The method estimates the unknown proportion of those 
elements in a population which possess a certain characteristic of 
interest (Chase and Bown, 1986). The 70 rings of the study represent 
a=70, and simple approximation procedures based on an approximate normal 
distribution for x, or p = x/n, can be used when n is large, n>30. 
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The statistical test is applied to the criterion for selecting the 
ring size for the population proportion chosen in order to ensure that 
rings will stay in the eye for 7 days. The optimal size criterion for 
rings, D, is 1.18L< D <1.23L» where L is the eye size measured from the 
medial canthus to the lateral canthus. In order to check the reliability 
of the retention results (Table 24) for the population proportion, a 
point estimate (p) for a population proportion (P) was first calculated. 
A point estimate, called the proportion of success, for P is p = x/n = 
56/70 = 0.80, for 56 rings that were retained for 7 days compared with 
the 70 rings studied (80%). Thus, x is total number of rings that were 
retained for a 7-day period and n is the total number of rings (n). 
However, if a point estimate (p) is used for the population proportion 
(P), there is usually an error. Thus, a confidence interval for P is of 
Interest. In order to find the maximum error of the population estimate 
(for any group of cattle) with a 95% confidence interval, the level of 
confidence, l-a= 0.95, and a point estimate, p, which equals 0.8 in this 
case (or q=0.2 for the fraction of the failures) must be obtained. Then, 
since n is large, from standard normal z-Varlate Probabilities Table, the 
following can be obtained. 
z(_^ ) = z(0.025) = 1.96 
Also, the 95% confidence interval is 
P - z(i^ )V^  < P < p + 2(-%)V^  
or upon substitution of values for the terms in the above equation, 
0.8 - (1.96^ 0'8)(0.2) < p < 0.8 + (1.96^ y^ ^^ ^^ ^^ Z^  
which reduces to 
0.8 - 0.0937 < P < 0.8 + 0.0937 
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or upon simplification, 
0.706 < P < 0.894 
The maximum error of the estimate is 
E = = (1.96^ yS^ 1^ 2lIl o 0.0937 
This Indicates that with 95% confidence, the success rate for 
retention of rings for 7 days in the population proportion of rings for 
any large group of cattle is between 70.6% and 89.4%. That is, if P is 
estimated by p = (x/n) = 0.8, there is a 95% suri^  that this estimate 
will be in error by less than 0.0937 (or 0.8 ± 0.0937). 
Physical conditions of ring devices after removal 
As soon as the rings were removed, their surfaces were observed (in 
a dry condition) using a stereo-microscope (magnification: X 160). Table 
26 summarizes the physical condition of rings removed from the cattle 
tabulated in rows 2, 3 and 4 of Table 24. 
Most of ring devices that were observed after removal had smooth 
surfaces. A few ring devices had small surface pores in the hydrogel 
coating layer. This came from the solvent evaporation during hydrogel 
coating process. There was no foreign material build-up on the surfaces 
during the retention period. Most rings were white; however, some of 
ring devices were yellowish, and had dirt on the surfaces. Ring devices 
of row 4 of Table 24 compared with those of rows 2 and 3 were in a 
somewhat better condition after removal. Some circular cracks occurred 
in the rings. Scanning electron microscopy was used to characterize the 
surfaces of two ring devices. Figure 15 represents of a segment of a 
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Joint separation^  
partial complete 
Crack 
only both** H 
Bending^  
H L VL 
2d 15 10 3 0 4 10 0 5 0 
3 19 12 3 1 6 3 7 9 0 
4 13 6 0 1 1 0 1 3 9 
Total 47 28 6 2 11 13 8 17 9 
% 100 59.6 12.8 4.3 23.4 27. 7 17 36. 2 19.1 
R^lngs with a partial joint separation can be retained in the 
eye, but rings with a complete joint separation must be removed. 
B^oth means cracks accompanying separation. 
B^ending height is determined by the extent of bowing 
distortion measured as a height of the ring above a flat surface 
(see Figure 3). It is divided into four groups ; H - high (> 2 cm), 
M - medium (1 -2 cm), L - low (0.5 - 1 cm) and VL - very low (< 0.5 cm). 
T^he surface of rings of row 2 was observed after washing rings 
with distilled water. 
hydrogel coated PVC tube (eye 757L). The hydrogel surface exhibits some 
porosity on a micrometer scale level in the form of open pores. 
Figure 16 shows the higher magnification view of Figure 15. Even though 
there are a few small pores, the surface is relatively smooth. 
A region on the surface of the area seen in Figure 15 is shown at a 
higher magnification in Figure 17. The pores are related to the 
evaporation of the solvent used for the dip coating solution. 
The multiple coating layers are seen in a cross sectional view of a ring 
in Figure 18. They are analogous to the various layers seen in an onion. 
Figure 17 shows that the larger pores (of the order of 20 micrometers in 
diameter) extend from the top to the bottom of a coating layer. 
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FIGURE 15. The surface of a hydrogel ocular insert removed from the left 
eye of animal no. 757 
FIGURE 16. Higher magnification view of the hydrogel ocular insert 
shown in Figure 15 
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FIGURE 17. Small pores on the surface of a hydrogel ocular insert 
shown in Figure 15 
1. 
. ' T--. ' 7 ' y 
e  ;  ,  .  H Y  D R O G  E l v  1 /  . /  f '  
. / t f- ' / 
:• • . •• ••• • • 
•  ' ,  /  .  P V C  
. J : 
0 0 0 9  1 . 0 K V  •  I B i ï r â  l ' | [ H 2  
FIGURE 18. High magnification cross-sectional view of the hydrogel 
ocular Insert (left eye, cow 750). Arrow indicates hydrogel 
coating on the PVC ring 
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DISCUSSION 
Fabrication of Hydrogel Ocular Inserts 
The average number of coats required to complete a ring device was 
influenced by the following factors: ambient temperature, humidi^  and 
the viscosity of hydrogel-solvent mixture. The fabrication of ring 
devices should be conducted in an inert atmosphere at 15 - 20°C to insure 
that uniform coatings will be built-up. 
In vivo Drug Release Test of Ocular Inserts 
Tear samples were collected from the eyes of healthy cows by using 
cotton swabs. The tears contained tylosin tartrate released from 
medicated rings in the eyes. The antibiotic release rate was 
characterized using a multiple spotting TLC technique. Most of the spots 
of tear samples collected from healthy cows were detectable. However, 
some traces on the plates were elongated, and this complicated the TLC 
analysis. This was probably due to natually occurring substances in the 
tears. 
The drug release rates measured in in vivo experiments were lower 
than those seen from in vitro tests* This might result from the variable 
tearing rate seen during the in vivo tests. All of the ring devices 
studied released drug amounts above the minimum inhibitory concentration 
of tylosin (0.63 /ig/ml) necessary for treating IBK. 
However, in the in vivo drug release tests using infected animals, 
no drug was detected in the tear samples in which medicated ring devices 
were used. There are several reasons for this. The most likely reason 
was the difficulty to sample when the eyelids were sutured together. 
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Another method was used to gain some insight into the drug release 
characteristics for these ring tests. The weight for a ring before and 
after use gave a measure of the total amount of drug released from a 
ring. These amounts were similar to those seen for in vitro tests. 
Direct bacterial counts and clinical observations clearly showed that a 
sufficient amount of antibiotic was released to treat IBK or to provide 
therapeutic protection. 
Antibiotic Susceptibility 
M. bovis was sensitive to tylosln tartrate in the antibiotic 
susceptibility test. The effectiveness of l^osln tartrate as the 
treatment drug can be seen in Figures 4 - 13. Within one day after 
inserting a ring device containing tylosln tartrate, the number of 
Moraxella bovis colonies was reduced rapidly to negligible levels. 
Reproduction of Disease 
In order to reproduce the disease (pinkeye) in the eyes of healthy 
calves, the ultraviolet radiation preconditioning method was used. 
Ninety five percent of the eyes (19 of 20 eyes) of Infection studies 
reproduced ^  bovis in the eyes. Each eye was inoculated with a ^  bovis 
inoculum having a concentration of 2.4 x 10^  - 1.6 x 10^  colony-forming 
units/ml. 
Quantitative Characterization of bovis 
Although initially suturing of eyelids was performed in order to 
prevent the ring devices from falling out, the sutures usually pulled out 
within 3 days. Additional tests showed that this technique was not 
necessary in order to retain the ring devices in the eye for 7 days. 
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Four rings of group IV showed good retention characteristics without the 
use of sutures. 
Table 12 and Figures 4-13 show the quantitative patterns for 
changes In the number of ^  bovls (bacteria) In treated and untreated 
Infected eyes during 14 day test periods. The general trend of bacterial 
growth In the eyes of calves was as follows. First, after Inoculating 
the eyes with M. bovls, the bacteria Increased rapidly to levels of 10^  -
10^  CFU/swab. Second, after Inserting a medicated ring device Into an 
eye of calves at day 7 of the Infection test, the number of bacterial 
colony forming units associated with tear samples from the treated eyes 
dropped to negligible levels compared with several tens of thousands of 
colony forming units found to be associated with tear samples from the 
control eyes which received non-medicated rings at the same time. Thus, 
the medicated ring treatment was very effective In suppressing the 
bacterial growth within a short time (about 1 or 2 days). The released 
drug directly contacts the Infected area and the antibiotic Is released 
continuously at therapeutic levels. 
In general, results of calf groups I, II, II and IV Indicated that 
almost all of the calf eyes contained large numbers of H. bovls before 
the treatment of Inserting a medicated ring into one eye and a 
non-medicated ring (a control) Into the other eye of each calf at day 7 
of the Infection and treatment experiment. The number of colony forming 
units found in swab samples of tears from the eyes were seen to decrease 
dramatically within a day after Insertion of medicated rings. By taking 
these samples during the 7-day period following Insertion of the rings. 
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an Index of changes occurring in the eyes during the insertion period was 
obtained. 
At the end of the tests, all rings were removed (day 14). Those 
eyes that had contained non-medicated rings then received medicated 
rings, and subsequent tear sampling for control eyes showed that the 
number of M. bovis colony forming units present within a day after 
insertion of these medicated rings became negligible. 
There were differences in the degree of susceptibility of the calves 
to the ^  bovis infection, and in one eye of one of the 10 calves 
studied, analysis of tear samples indicated that no M. bovis colony 
forming units were detectable throughout the entire test period (Table 
12, calf 8002L). However, data obtained for the tear samples from the 
other 19 eyes clearly established the effectiveness of the medicated ring 
treatment. 
In a comparison of the use of medicated rings in control eyes (day 
14) with that of the use of a subconjunctival injection of Azimycii^ i^n a 
control eye (day 14), the analyses of tear samples from both of these two 
types of treatments showed that the numbers of ^  bovis colony forming 
units dropped to negligible levels. 
Clinical Characterization of Infected Eyes 
Sixty percent of the eyes in the infected studies (12 out of 20) 
showed clinical signs of IBK. Of the eyes receiving medicated rings and 
showing signs of IBK, 50% exhibited significant improvement (4 of 8) in 
that no apparent signs of IBK were observed at the end of the treatment 
period. The other 50% were in healing stages; however, it is not clear 
if the medicated rings played a major role in these cases. However, 20% 
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of Che eyes receiving non-medicated rings (2 of 10) continued to worsen 
gradually with time. 
In vivo Experiment for the Retention of Ring Devices 
The retention tests for the ocular inserts provided useful 
information for selecting rings of a size suitable for treating the 
infected eyes. The results (Table 24) indicate that the hypothesis, D = 
1.2 times the eye size, where D is the optimal size of a ring is good. 
The acceptable range of ring sizes is determined as 1.18L < ring size < 
1.23L, where L is the measured eye size. Results can be improved further 
by eliminating the ring joint. A joint is a point of weakness. If a 
joint separates partially or fully, eye irritation may result. This may 
lead to premature removal of the ring. In addition, preconditioning 
times for the rings should be long enough to soften the ring coating. 
A comparison between this method and the only published data 
providing sufficient details of retention experiments (the method of 
Punch et al. (1987b)) is shown in Table 27. The listings of size 
selection criteria, ring materials studied, thickness of rings used, 
level of irritation seen, and success rates for the two methods are given 
in Table 27. 
The current method offers significant advantages over that of Punch 
et al. method: (1) the use of smaller size of tubing (less than 2 mm in 
diameter) results in less eye irritation than the use of a larger size of 
tubing (4 or 6 mm); (2) the size criterion that ring size is proportional 
to the measured eye size correlates with high retention rates for the 
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TABLE 27. Comparison of ring selection factors based on the current 
method and the method of Punch et al. (1987b) 
Item Current method Punch et al. method 
Basis Measure palpebral aperture 
(use ruler) 
Same 
(use vernier caliper) 
Equation^  
- 1.2 X Dj 
1.18Dj < Do < 1.23Dj 
LT = (Dj+R)7r 
= DTTT 
Lj » (Ûj+R/2)7r 
Tubing 
diameter 
1.3 - 1.7 mm 2 mm, 4 mm, 6 mm 
Side 
effect 
Little irritation High percentage of rings 
6 mm in thickness resulted 





Nylon and PVC tubing 
(2 mm) (4 mm, 6 mm) 
Success 
rate (Avg.) 




Eye measurement Equations, tubing diameter 
and tubing material 
Here, ; outside diameter of ring device; Dr : diameter of 
palpebral aperture; . length of tubing; R ; tubing diameter. 
desired 7-day retention period; (3) the hydrogel coating material is 
nonirritating to the eye. 
The application of the current sizing selection criterion for rings 
provides a basis to estimate the success rate for 7-day ring retention 
requirements. The estimate of the success rate (for ring retention for 




Ten calves were tested to evaluate the effectiveness of medicated 
hydrogel ocular inserts for treating pinkeye in cattle. An ultraviolet 
radiation method followed by instillation of ^  bovis reproduced IBK in 
19 out of 20 eyes. The severity of the ocular infection varied from a 
mild stage to a more severe stage (corneal ulceration). 
M. bovis was sensitive to tylosin tartrate. Medicated rings were 
very effective in suppressing the growth of bacteria within 1 to 2 days. 
The infection was monitored by sampling bacteria from the eyes, and 
noting the change in the number of colony forming units found from the 
tear solutions in the various swab samples taken at different times and 
conditions (i.e., before and after medicated rings were used). Upon 
application of the medicated rings, usually within a day the bacterial 
numbers had decreased to negligible levels and remained very low or 
nondetectable throughout a 7-day period after insertion. Eyelids were 
sutured together (8 out of 10 calves) to insure that the rings would 
remain in place throughout an experiment. 
There were 2 cases in which a significant change was seen in the 
clinical signs of IBK after the infected eyes received medicated rings. 
For these cases, corneal lesions were present at the time of insertion of 
the medicated rings. Seven days later when the medicated rings were 
removed, the eyes appeared to be normal. The contribution of the use of 
medicated rings to improving healing is not established; however, the 
numbers of bacteria in the eyes drop quickly and remain low for several 
days after insertion of medicated rings, and this may improve the 
environment for healing. 
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As another major experiment, retention tests were performed to 
develop an optimal size criterion for preselection of rings, and then 
specific retention tests were performed to evaluate the sizing criterion. 
As a result of the preliminary test, the optimal size criterion was 
identified as 1.18L < ring size <1.23L, where L is the eye size which is 
measured from medial canthus to lateral canthus. Then, the usefulness of 
this criterion was tested using 70 eyes of 38 healthy cows. Eighty 
percent of the rings were retained for at least 7 days. This represents 
a major Improvement compared with the results presented by other 
Investigators (Hughes and Pugh, 1975; Punch et al., 1987b). This 
improvement comes from the use of a thinner ring, the application of a 
better ring size criterion, and the selection of a non-irritant ring 
surface material (hydrogel). The success rate of the population (any 
large group of cattle) was estimated to be within 70% to 90% at the 95% 
confidence level. 
The ring devices are very useful in treating IBK, and can be 
utilized easily and effectively in the field. The devices release 
suitable amounts of drug continuously, are easy to insert and to retain, 
and are inexpensive. 
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